|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Fiscal Year Ended December 31, 2016
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
|
New York Stock Exchange, Inc.
|
|
Large accelerated filer
x
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
Product
|
|
Annual Capacity
|
|
End Uses
|
|
|
|
(Millions of pounds)
|
|
|
|
Ethylene
(1)
|
|
2,990
|
|
|
Polyethylene, ethylene dichloride ("EDC"), styrene,
ethylene oxide/ethylene glycol
|
Low-Density Polyethylene ("LDPE")
|
|
1,500
|
|
|
High clarity packaging, shrink films, laundry and dry
cleaning bags, ice bags, frozen foods packaging, bakery
bags, coated paper board, cup stock, paper folding
cartons, lids, closures and general purpose molding
|
Linear Low-Density Polyethylene
("LLDPE")
|
|
1,070
|
|
|
Heavy-duty films and bags, general purpose liners
|
Styrene
|
|
570
|
|
|
Consumer disposables, packaging material, appliances,
paints and coatings, resins and building materials
|
(1)
|
Production capacity owned by OpCo.
|
Product
(1)
|
|
Annual Capacity
(2)
|
|
End Uses
|
|
|
|
(Millions of pounds)
|
|
|
|
Specialty PVC
|
|
1,100
|
|
|
Automotive sealants, cable sheathing, medical
applications and other applications
|
Commodity PVC
|
|
5,700
|
|
|
Construction materials including pipe, siding, profiles for
windows and doors, film and sheet for packaging
and other applications
|
VCM
|
|
6,980
|
|
|
PVC
|
Chlorine
|
|
7,140
|
|
|
VCM, organic/inorganic chemicals, bleach
|
Caustic Soda
|
|
7,860
|
|
|
Pulp and paper, organic/inorganic chemicals,
neutralization, alumina
|
Chlorinated Derivative Products
|
|
2,290
|
|
|
Coatings, flavorants, films, refrigerants, water treatment applications, chemicals and pharmaceutical production
|
Ethylene
(3)
|
|
630
|
|
|
VCM
|
Building Products
|
|
1,950
|
|
|
Pipe: water and sewer, plumbing, irrigation, conduit;
fittings; profiles and foundation building products;
window and door components; fence and deck
components; siding, trim and mouldings; film and sheet
|
(1)
|
EDC, a VCM intermediate product, is not included in the table.
|
(2)
|
Includes capacity related to our
95%
and
60%
owned Asian joint ventures.
|
(3)
|
Production capacity owned by OpCo.
|
Category
|
|
Number
|
|
Olefins segment
|
|
840
|
|
Vinyls segment
|
|
7,700
|
|
Corporate and other
|
|
330
|
|
•
|
general economic conditions, including in the United States, Europe and Asia;
|
•
|
new capacity additions in North America, Asia and the Middle East;
|
•
|
the level of business activity in the industries that use our products;
|
•
|
competitor action;
|
•
|
technological innovations;
|
•
|
currency fluctuations;
|
•
|
increases in interest rates;
|
•
|
international events and circumstances;
|
•
|
war, sabotage, terrorism and civil unrest;
|
•
|
governmental regulation, including in the United States, Europe and Asia;
|
•
|
severe weather and natural disasters; and
|
•
|
credit worthiness of customers and vendors.
|
•
|
product price;
|
•
|
balance of product supply/demand;
|
•
|
material, technology and process innovation;
|
•
|
technical support and customer service;
|
•
|
quality;
|
•
|
reliability of raw material and utility supply;
|
•
|
availability of potential substitute materials; and
|
•
|
product performance.
|
•
|
the emergence of new domestic and international competitors;
|
•
|
the rate of capacity additions by competitors;
|
•
|
changes in customer base due to mergers;
|
•
|
the intensification of price competition in our markets;
|
•
|
the introduction of new or substitute products by competitors; and
|
•
|
the technological innovations of competitors.
|
•
|
pipeline leaks and ruptures;
|
•
|
explosions;
|
•
|
fires;
|
•
|
severe weather and natural disasters;
|
•
|
mechanical failure;
|
•
|
unscheduled downtime;
|
•
|
labor difficulties;
|
•
|
transportation interruptions;
|
•
|
transportation accidents involving our chemical products;
|
•
|
remediation complications;
|
•
|
chemical spills;
|
•
|
discharges or releases of toxic or hazardous substances or gases;
|
•
|
storage tank leaks;
|
•
|
other environmental risks;
|
•
|
sabotage;
|
•
|
terrorist attacks; and
|
•
|
political unrest.
|
•
|
the diversion of management's attention to integration matters;
|
•
|
difficulties in achieving anticipated cost savings, synergies, business opportunities and growth prospects from combining Axiall's business with our business;
|
•
|
difficulties entering new markets or manufacturing in new geographies where we have no or limited direct prior experience;
|
•
|
difficulties in the integration of operations and systems;
|
•
|
difficulties in the assimilation of employees;
|
•
|
difficulties in managing the expanded operations of a significantly larger and more complex company;
|
•
|
difficulties in successfully managing relationships with our strategic partners and our supplier and customer base;
|
•
|
difficulties in maintaining existing, and establishing new, business relationships; and
|
•
|
difficulties in attracting and retaining key personnel.
|
•
|
unexpectedly long delivery times for, or shortages of, key equipment, parts or materials;
|
•
|
shortages of skilled labor and other personnel necessary to perform the work;
|
•
|
delays and performance issues;
|
•
|
failures or delays of third-party equipment vendors or service providers;
|
•
|
unforeseen increases in the cost of equipment, labor and raw materials;
|
•
|
work stoppages and other labor disputes;
|
•
|
unanticipated actual or purported change orders;
|
•
|
disputes with contractors and suppliers;
|
•
|
design and engineering problems;
|
•
|
latent damages or deterioration to equipment and machinery in excess of engineering estimates and assumptions;
|
•
|
financial or other difficulties of our contractors and suppliers;
|
•
|
sabotage;
|
•
|
terrorist attacks;
|
•
|
interference from adverse weather conditions; and
|
•
|
difficulties in obtaining necessary permits or in meeting permit conditions.
|
•
|
a portion of our cash flows from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes, including the payment of dividends;
|
•
|
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
|
•
|
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flows to improve their operations;
|
•
|
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
|
•
|
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
|
•
|
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
|
•
|
pay dividends on, redeem or repurchase our capital stock;
|
•
|
make investments and other restricted payments;
|
•
|
incur additional indebtedness or issue preferred stock;
|
•
|
create liens;
|
•
|
permit dividend or other payment restrictions on our restricted subsidiaries;
|
•
|
sell all or substantially all of our assets or consolidate or merge with or into other companies;
|
•
|
engage in transactions with affiliates; and
|
•
|
engage in sale-leaseback transactions.
|
•
|
shortages and inconsistent quality of equipment, materials, and labor;
|
•
|
labor costs and productivity;
|
•
|
work stoppages;
|
•
|
contractor or supplier delay or non-performance under construction or other agreements or non-performance by other major participants in construction projects;
|
•
|
delays in or failure to receive necessary permits, approvals, tax credits, and other regulatory authorizations;
|
•
|
delays associated with start-up activities, including major equipment failure, system integration, and operations, and/or unforeseen engineering problems;
|
•
|
changes in project design or scope;
|
•
|
impacts of new and existing laws and regulations, including environmental laws and regulations;
|
•
|
the outcome of legal challenges to projects, including legal challenges to regulatory approvals;
|
•
|
failure to construct in accordance with licensing requirements;
|
•
|
continued public and policymaker support for such projects;
|
•
|
adverse weather conditions or natural disasters;
|
•
|
sabotage;
|
•
|
terrorist attacks;
|
•
|
environmental and geological conditions;
|
•
|
delays or increased costs to interconnect facilities; and
|
•
|
other unanticipated cost increases.
|
•
|
we may fail to integrate the businesses we acquire into a cohesive, efficient enterprise;
|
•
|
our resources, including management resources, are limited and may be strained if we engage in a large acquisition or significant number of acquisitions, and acquisitions may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; and
|
•
|
our failure to retain key employees and contracts of the businesses we acquire.
|
•
|
diversion of management's attention away from normal daily business operations;
|
•
|
delays and cost overruns;
|
•
|
loss of or delays in accessing data;
|
•
|
increased demand on our operations support personnel;
|
•
|
initial dependence on unfamiliar systems while training personnel to use new systems; and
|
•
|
increased operating expenses resulting from training, conversion and transition support activities.
|
•
|
the composition of our Board of Directors and, through the Board, any determination with respect to our business direction and policies, including the appointment and removal of officers and the determination of compensation;
|
•
|
any determinations with respect to mergers or other business combinations or the acquisition or disposition of assets;
|
•
|
our financing decisions, capital raising activities and the payment of dividends; and
|
•
|
amendments to our amended and restated certificate of incorporation or amended and restated bylaws.
|
•
|
business opportunities that may be presented to the principal stockholder affiliates and to our officers and directors associated with the principal stockholder affiliates, and competition between the principal stockholder affiliates and us within the same lines of business;
|
•
|
the solicitation and hiring of employees from each other; and
|
•
|
agreements with the principal stockholder affiliates relating to corporate services that may be material to our business.
|
•
|
future operating rates, margins, cash flows and demand for our products;
|
•
|
industry market outlook, including the price of crude oil;
|
•
|
production capacities;
|
•
|
currency devaluation;
|
•
|
our ability to borrow additional funds under the Credit Agreement;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our ability to meet debt obligations under our debt instruments;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industry;
|
•
|
timing, funding and results of capital projects, such as the expansion program at our Calvert City facility and the construction of the LACC plant;
|
•
|
results of acquisitions, including our acquisition of Axiall (including the benefits, results and effects thereof);
|
•
|
health of our customer base;
|
•
|
pension plan obligations, funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other GHG emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and other countries and political unrest in other areas;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations;
|
•
|
technological developments;
|
•
|
our ability to realize anticipated benefits of the Merger and to integrate Axiall's business;
|
•
|
charges or other liabilities relating to the Merger;
|
•
|
the significant indebtedness that we have incurred in connection with the Merger;
|
•
|
our ability to integrate acquired businesses other than Axiall;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Location
|
|
Principal Products
|
Lake Charles, Louisiana
|
|
Ethylene, polyethylene, styrene, VCM, chlorine, caustic soda,
chlorinated derivative products, electricity
|
Longview, Texas
(1)
|
|
Polyethylene, polyethylene wax
|
Calvert City, Kentucky
(2)
|
|
PVC, VCM, chlorine, caustic soda, ethylene
|
Plaquemine, Louisiana
|
|
PVC, VCM, chlorine, caustic soda, electricity
|
Geismar, Louisiana
|
|
PVC, VCM, chlorine, caustic soda
|
Gendorf, Bavaria, Germany
(1)
|
|
PVC, VCM, chlorine, caustic soda
|
Burghausen, Bavaria, Germany
(1)
|
|
PVC
|
Knapsack, North Rhine-Westphalia, Germany
(1)
|
|
PVC, VCM, chlorine, caustic soda
|
Cologne, North Rhine-Westphalia, Germany
(1)
|
|
PVC
|
(1)
|
We lease the land on which our facilities are located.
|
(2)
|
We lease a portion of the land on which our Calvert City facility is located.
|
|
|
High
|
|
Low
|
|
Cash Dividends
Declared
|
||||||
Year Ended December 31, 2016
|
|
|
|
|
|
|
||||||
4th Quarter
|
|
$
|
59.17
|
|
|
$
|
49.84
|
|
|
$
|
0.1906
|
|
3rd Quarter
|
|
53.50
|
|
|
41.21
|
|
|
0.1906
|
|
|||
2nd Quarter
|
|
52.22
|
|
|
39.88
|
|
|
0.1815
|
|
|||
1st Quarter
|
|
53.60
|
|
|
41.01
|
|
|
0.1815
|
|
|||
Year Ended December 31, 2015
|
|
|
|
|
|
|
||||||
4th Quarter
|
|
$
|
62.09
|
|
|
$
|
52.86
|
|
|
$
|
0.1815
|
|
3rd Quarter
|
|
66.69
|
|
|
49.82
|
|
|
0.1815
|
|
|||
2nd Quarter
|
|
78.59
|
|
|
67.98
|
|
|
0.1650
|
|
|||
1st Quarter
|
|
72.49
|
|
|
55.20
|
|
|
0.1650
|
|
Period
|
|
Total Number
of Shares
Purchased
(1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(2)
|
||||||
October 2016
|
|
1,936
|
|
|
$
|
53.35
|
|
|
—
|
|
|
$
|
171,285,000
|
|
November 2016
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
December 2016
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
Total
|
|
1,936
|
|
|
$
|
53.35
|
|
|
—
|
|
|
|
(1)
|
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
In November 2014, our Board of Directors authorized a $250.0 million stock repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150.0 million. As of
December 31, 2016
,
4,193,598
shares of our common stock had been acquired at an aggregate purchase price of approximately
$228.7 million
under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flows from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
Plan Category
|
|
Number of securities
to be issued upon
exercise of outstanding options,
warrants and rights
(a)
|
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
|
Number of securities
remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column
(a))
(c)
|
||||
Equity compensation plans approved by security holders
|
|
2,002,293
|
|
|
$
|
23.69
|
|
|
5,280,203
|
|
Equity compensation plans not approved by security holders
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
Total
|
|
2,002,293
|
|
|
$
|
23.69
|
|
|
5,280,203
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in thousands, except share amounts, per share data and volume data)
|
||||||||||||||||||
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
5,075,456
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
$
|
3,571,041
|
|
Gross profit
|
|
980,562
|
|
|
1,185,191
|
|
|
1,317,350
|
|
|
1,101,438
|
|
|
736,960
|
|
|||||
Selling, general and administrative expenses
|
|
295,436
|
|
|
225,364
|
|
|
183,745
|
|
|
147,974
|
|
|
121,609
|
|
|||||
Transaction and integration-related costs
|
|
103,672
|
|
|
—
|
|
|
9,614
|
|
|
—
|
|
|
—
|
|
|||||
Income from operations
|
|
581,454
|
|
|
959,827
|
|
|
1,123,991
|
|
|
953,464
|
|
|
615,351
|
|
|||||
Interest expense
|
|
(79,473
|
)
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|
(43,049
|
)
|
|||||
Debt retirement costs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,082
|
)
|
|||||
Gain from sales of equity securities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,429
|
|
|||||
Other income (expense), net
(2)
|
|
56,398
|
|
|
38,270
|
|
|
(2,721
|
)
|
|
6,790
|
|
|
3,520
|
|
|||||
Income before income taxes
|
|
558,379
|
|
|
963,441
|
|
|
1,083,918
|
|
|
942,172
|
|
|
585,169
|
|
|||||
Provision for income taxes
|
|
138,520
|
|
|
298,396
|
|
|
398,902
|
|
|
331,747
|
|
|
199,614
|
|
|||||
Net income
|
|
419,859
|
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|
385,555
|
|
|||||
Net income attributable to noncontrolling
interests
|
|
21,000
|
|
|
19,035
|
|
|
6,493
|
|
|
—
|
|
|
—
|
|
|||||
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
398,859
|
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
|
$
|
610,425
|
|
|
$
|
385,555
|
|
Earnings Per Share Attributable to
Westlake Chemical Corporation:
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
|
$
|
4.57
|
|
|
$
|
2.89
|
|
Diluted
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
|
$
|
2.88
|
|
Weighted average shares outstanding
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
129,367,712
|
|
|
131,823,707
|
|
|
133,111,230
|
|
|
133,224,256
|
|
|
132,578,858
|
|
|||||
Diluted
|
|
129,974,822
|
|
|
132,301,812
|
|
|
133,643,414
|
|
|
133,779,250
|
|
|
133,282,990
|
|
|||||
Balance Sheet Data (end of period):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
459,453
|
|
|
$
|
662,525
|
|
|
$
|
880,601
|
|
|
$
|
461,301
|
|
|
$
|
790,078
|
|
Marketable securities
|
|
—
|
|
|
520,144
|
|
|
—
|
|
|
239,388
|
|
|
124,873
|
|
|||||
Restricted cash
|
|
160,527
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Working capital
(4)
|
|
1,225,233
|
|
|
1,652,547
|
|
|
1,474,107
|
|
|
1,244,224
|
|
|
1,352,903
|
|
|||||
Total assets
|
|
10,890,253
|
|
|
5,569,285
|
|
|
5,207,532
|
|
|
4,053,960
|
|
|
3,404,757
|
|
|||||
Total long-term debt, net
|
|
3,678,654
|
|
|
758,148
|
|
|
757,539
|
|
|
756,930
|
|
|
756,322
|
|
|||||
Total Westlake Chemical Corporation
stockholders' equity
|
|
3,523,629
|
|
|
3,265,878
|
|
|
2,911,511
|
|
|
2,418,603
|
|
|
1,872,256
|
|
|||||
Cash dividends declared per share
(3) (5)
|
|
$
|
0.7442
|
|
|
$
|
0.6930
|
|
|
$
|
0.5820
|
|
|
$
|
0.4125
|
|
|
$
|
2.1363
|
|
Other Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating activities
|
|
$
|
833,852
|
|
|
$
|
1,078,836
|
|
|
$
|
1,032,376
|
|
|
$
|
752,729
|
|
|
$
|
612,087
|
|
Investing activities
|
|
(2,562,800
|
)
|
|
(1,006,176
|
)
|
|
(773,205
|
)
|
|
(1,002,238
|
)
|
|
(466,971
|
)
|
|||||
Financing activities
|
|
1,533,217
|
|
|
(286,812
|
)
|
|
164,640
|
|
|
(79,268
|
)
|
|
(180,939
|
)
|
|||||
Depreciation and amortization
|
|
377,666
|
|
|
245,757
|
|
|
208,486
|
|
|
157,808
|
|
|
144,541
|
|
|||||
Capital expenditures
|
|
628,483
|
|
|
491,426
|
|
|
431,104
|
|
|
679,222
|
|
|
386,882
|
|
|||||
EBITDA
(6)
|
|
1,015,518
|
|
|
1,243,854
|
|
|
1,329,756
|
|
|
1,118,062
|
|
|
772,759
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in thousands, except share amounts, per share data and volume data)
|
||||||||||||||||||
External Sales Volume
(millions of pounds):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Olefins Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Polyethylene
|
|
2,392
|
|
|
2,445
|
|
|
2,364
|
|
|
2,244
|
|
|
2,230
|
|
|||||
Styrene, feedstock and other
|
|
794
|
|
|
1,182
|
|
|
941
|
|
|
1,094
|
|
|
925
|
|
|||||
Vinyls Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
PVC, caustic soda and other
|
|
8,118
|
|
|
5,026
|
|
|
3,174
|
|
|
1,995
|
|
|
1,822
|
|
|||||
Building products
|
|
770
|
|
|
629
|
|
|
572
|
|
|
487
|
|
|
423
|
|
(1)
|
The historical selected financial and operational data should be read together with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 8, Financial Statements and Supplementary Data included in this Form 10-K.
|
(2)
|
Other income (expense), net is composed of the realized gain from previously held outstanding shares of common stock of Axiall, financing costs incurred in connection with the Merger, interest income, income or loss from equity method investments, dividend income, gains or losses from sales of securities, foreign exchange currency gains or losses, gain on acquisition, impairment of equity method investments, management fee income and other gains and losses.
|
(3)
|
On February 14, 2014, our Board of Directors authorized a two-for-one split of our common stock. Stockholders of record as of February 28, 2014 were entitled to one additional share for every share outstanding, which was distributed on March 18, 2014. All share amounts and per share data for the years prior to December 31, 2014 have been restated to reflect the effect of the two-for-one stock split.
|
(4)
|
Working capital equals current assets less current liabilities.
|
(5)
|
Cash dividends declared for the year ended December 31, 2012 includes a special dividend of $1.875 per share (on a post-split basis) paid on December 12, 2012.
|
(6)
|
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose a non-GAAP financial measure is generally defined by the SEC as one that purports to measure historical and future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. We have included EBITDA in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. EBITDA allows for meaningful company-to-company performance comparisons by adjusting for factors such as interest expense, depreciation and amortization and taxes, which often vary from company to company. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flows and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented in this Form 10-K may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which is a necessary element of our operations. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only supplementally. The following table reconciles EBITDA to net income and to net cash provided by operating activities.
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in thousands)
|
||||||||||||||||||
Net cash provided by operating activities
|
|
$
|
833,852
|
|
|
$
|
1,078,836
|
|
|
$
|
1,032,376
|
|
|
$
|
752,729
|
|
|
$
|
612,087
|
|
Changes in operating assets and liabilities
and other |
|
(339,165
|
)
|
|
(371,794
|
)
|
|
(273,083
|
)
|
|
(34,453
|
)
|
|
(244,683
|
)
|
|||||
Provision for doubtful accounts
|
|
(4,095
|
)
|
|
(956
|
)
|
|
(301
|
)
|
|
(5,514
|
)
|
|
(229
|
)
|
|||||
Amortization of debt issuance costs
|
|
(3,159
|
)
|
|
(2,004
|
)
|
|
(1,673
|
)
|
|
(1,459
|
)
|
|
(1,514
|
)
|
|||||
Stock-based compensation expense
|
|
(14,193
|
)
|
|
(10,196
|
)
|
|
(9,261
|
)
|
|
(6,966
|
)
|
|
(6,127
|
)
|
|||||
Loss from disposition of property, plant
and equipment
|
|
(8,629
|
)
|
|
(10,891
|
)
|
|
(4,181
|
)
|
|
(5,039
|
)
|
|
(3,886
|
)
|
|||||
Gains (losses) realized on previously held
shares of Axiall common stock and from
sales of securities
|
|
53,754
|
|
|
3,798
|
|
|
1,212
|
|
|
(19
|
)
|
|
16,429
|
|
|||||
Gain on acquisition, net of loss on the
fair value remeasurement of preexisting
equity interest
|
|
—
|
|
|
21,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Impairment of equity method investments
|
|
—
|
|
|
(4,925
|
)
|
|
(6,747
|
)
|
|
—
|
|
|
—
|
|
|||||
Write-off of debt issuance costs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,277
|
)
|
|||||
Deferred income taxes
|
|
(100,677
|
)
|
|
(39,784
|
)
|
|
(58,967
|
)
|
|
(93,732
|
)
|
|
5,793
|
|
|||||
Windfall tax benefits from share-based
payment arrangements
|
|
2,624
|
|
|
1,646
|
|
|
6,704
|
|
|
5,449
|
|
|
11,967
|
|
|||||
(Loss) income from equity method
investments, net of dividends
|
|
(1,503
|
)
|
|
632
|
|
|
424
|
|
|
(199
|
)
|
|
(3,005
|
)
|
|||||
Other gains (losses), net
|
|
1,050
|
|
|
(362
|
)
|
|
(1,487
|
)
|
|
(372
|
)
|
|
—
|
|
|||||
Net income
|
|
419,859
|
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|
385,555
|
|
|||||
Add:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Provision for income taxes
|
|
138,520
|
|
|
298,396
|
|
|
398,902
|
|
|
331,747
|
|
|
199,614
|
|
|||||
Interest expense
|
|
79,473
|
|
|
34,656
|
|
|
37,352
|
|
|
18,082
|
|
|
43,049
|
|
|||||
Depreciation and amortization
|
|
377,666
|
|
|
245,757
|
|
|
208,486
|
|
|
157,808
|
|
|
144,541
|
|
|||||
EBITDA
|
|
$
|
1,015,518
|
|
|
$
|
1,243,854
|
|
|
$
|
1,329,756
|
|
|
$
|
1,118,062
|
|
|
$
|
772,759
|
|
•
|
the availability of feedstock from shale gas and oil drilling;
|
•
|
supply and demand for crude oil;
|
•
|
shortages of raw materials due to increasing demand;
|
•
|
ethane and liquefied natural gas exports;
|
•
|
capacity constraints due to higher construction costs for investments, construction delays, strike action or involuntary shutdowns;
|
•
|
the general level of business and economic activity; and
|
•
|
the direct or indirect effect of governmental regulation.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(dollars in thousands, except per share data)
|
||||||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,462,407
|
|
|
$
|
1,650,964
|
|
|
$
|
1,922,535
|
|
Styrene, feedstock and other
|
|
431,227
|
|
|
609,149
|
|
|
801,155
|
|
|||
Total Olefins
|
|
1,893,634
|
|
|
2,260,113
|
|
|
2,723,690
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
2,492,562
|
|
|
1,718,359
|
|
|
1,203,332
|
|
|||
Building products
|
|
689,260
|
|
|
484,864
|
|
|
488,328
|
|
|||
Total Vinyls
|
|
3,181,822
|
|
|
2,203,223
|
|
|
1,691,660
|
|
|||
Total
|
|
$
|
5,075,456
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
557,806
|
|
|
$
|
747,436
|
|
|
$
|
1,013,825
|
|
Vinyls
|
|
174,141
|
|
|
254,452
|
|
|
142,740
|
|
|||
Corporate and other
|
|
(150,493
|
)
|
|
(42,061
|
)
|
|
(32,574
|
)
|
|||
Total income from operations
|
|
581,454
|
|
|
959,827
|
|
|
1,123,991
|
|
|||
Interest expense
|
|
(79,473
|
)
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|||
Other income (expense), net
|
|
56,398
|
|
|
38,270
|
|
|
(2,721
|
)
|
|||
Provision for income taxes
|
|
138,520
|
|
|
298,396
|
|
|
398,902
|
|
|||
Net income
|
|
419,859
|
|
|
665,045
|
|
|
685,016
|
|
|||
Net income attributable to noncontrolling interests
|
|
21,000
|
|
|
19,035
|
|
|
6,493
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
398,859
|
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
Diluted earnings per share
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
||||||||
|
|
Average Sales
Price
|
|
Volume
|
|
Average Sales
Price
|
|
Volume
|
||||
Product sales price and volume percentage change
from prior year
|
|
|
|
|
|
|
|
|
||||
Olefins
|
|
-8.9
|
%
|
|
-7.3
|
%
|
|
-29.2
|
%
|
|
+12.2
|
%
|
Vinyls
|
|
-3.8
|
%
|
|
+48.3
|
%
|
|
-18.9
|
%
|
|
+49.1
|
%
|
Company average
|
|
-6.4
|
%
|
|
+20.1
|
%
|
|
-25.3
|
%
|
|
+26.3
|
%
|
|
|
Year Ended December 31,
|
|||||||
|
|
2016
|
|
2015
|
|
2014
|
|||
Average industry prices
(1)
|
|
|
|
|
|
|
|||
Ethane (cents/lb)
|
|
6.6
|
|
|
6.2
|
|
|
9.0
|
|
Propane (cents/lb)
|
|
11.4
|
|
|
10.7
|
|
|
24.7
|
|
Ethylene (cents/lb)
(2)
|
|
26.9
|
|
|
30.6
|
|
|
58.4
|
|
Polyethylene (cents/lb)
(3)
|
|
65.3
|
|
|
71.6
|
|
|
85.0
|
|
Styrene (cents/lb)
(4)
|
|
64.8
|
|
|
60.7
|
|
|
82.1
|
|
Caustic ($/short ton)
(5)
|
|
645.0
|
|
|
581.0
|
|
|
589.4
|
|
Chlorine ($/short ton)
(6)
|
|
297.7
|
|
|
266.9
|
|
|
233.5
|
|
PVC (cents/lb)
(7)
|
|
69.7
|
|
|
66.0
|
|
|
68.8
|
|
(1)
|
Industry pricing data was obtained through IHS Chemical. We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
(3)
|
Represents average North American net transaction prices of polyethylene low density GP-Film grade over the period as reported by IHS Chemical.
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS Chemical.
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS Chemical.
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS Chemical.
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS Chemical.
|
|
|
Payment Due by Period
|
||||||||||||||||||
|
|
Total
|
|
2017
|
|
2018-2019
|
|
2020-2021
|
|
Thereafter
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Term loan
|
|
$
|
150.0
|
|
|
$
|
150.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Long-term debt
|
|
3,677.9
|
|
|
—
|
|
|
—
|
|
|
1,013.0
|
|
|
2,664.9
|
|
|||||
Operating leases
|
|
918.4
|
|
|
87.0
|
|
|
139.8
|
|
|
88.0
|
|
|
603.6
|
|
|||||
Capital leases
|
|
30.6
|
|
|
3.7
|
|
|
7.0
|
|
|
6.0
|
|
|
13.9
|
|
|||||
Pension benefits funding
|
|
280.7
|
|
|
5.6
|
|
|
26.4
|
|
|
38.1
|
|
|
210.6
|
|
|||||
Post-retirement healthcare benefits
|
|
111.6
|
|
|
8.7
|
|
|
16.8
|
|
|
16.3
|
|
|
69.8
|
|
|||||
Purchase obligations
|
|
5,869.3
|
|
|
1,713.4
|
|
|
1,568.5
|
|
|
1,379.1
|
|
|
1,208.3
|
|
|||||
Interest payments
|
|
2,191.1
|
|
|
166.3
|
|
|
330.7
|
|
|
300.6
|
|
|
1,393.5
|
|
|||||
Asset retirement obligations
|
|
37.1
|
|
|
5.4
|
|
|
3.6
|
|
|
3.6
|
|
|
24.5
|
|
|||||
Investment in LACC
|
|
165.6
|
|
|
81.0
|
|
|
84.6
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
13,432.3
|
|
|
$
|
2,221.1
|
|
|
$
|
2,177.4
|
|
|
$
|
2,844.7
|
|
|
$
|
6,189.1
|
|
Other Commercial Commitments
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Standby letters of credit
|
|
$
|
95.9
|
|
|
$
|
95.9
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
2016
|
||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||
|
|
|
|
|
||||
|
|
(dollars in millions)
|
||||||
Projected benefit obligation, end of year
|
|
$
|
799.3
|
|
|
$
|
125.2
|
|
Discount rate increases by 100 basis points
|
|
711.3
|
|
|
107.4
|
|
||
Discount rate decreases by 100 basis points
|
|
892.5
|
|
|
147.7
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Page
|
|
|
Management's Report on Internal Control over Financial Reporting
|
|
Report of Independent Registered Public Accounting Firm
|
|
Consolidated Financial Statements:
|
|
Consolidated Balance Sheets as of December 31, 2016 and 2015
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2016, 2015 and 2014
|
|
Consolidated Statements of Comprehensive Income for the Years Ended
December 31, 2016, 2015 and 2014
|
|
Consolidated Statements of Changes in Stockholders' Equity for the Years Ended
December 31, 2016, 2015 and 2014
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2016, 2015 and 2014
|
|
Notes to Consolidated Financial Statements
|
|
|
December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars, except
par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
459,453
|
|
|
$
|
662,525
|
|
Marketable securities
|
|
—
|
|
|
520,144
|
|
||
Accounts receivable, net
|
|
938,743
|
|
|
508,532
|
|
||
Inventories
|
|
801,100
|
|
|
434,060
|
|
||
Prepaid expenses and other current assets
|
|
48,493
|
|
|
14,489
|
|
||
Restricted cash
|
|
160,527
|
|
|
—
|
|
||
Deferred income taxes
|
|
—
|
|
|
35,439
|
|
||
Total current assets
|
|
2,408,316
|
|
|
2,175,189
|
|
||
Property, plant and equipment, net
|
|
6,420,062
|
|
|
3,004,067
|
|
||
Other assets, net
|
|
|
|
|
||||
Goodwill
|
|
946,553
|
|
|
62,016
|
|
||
Customer relationships
|
|
611,615
|
|
|
52,677
|
|
||
Other intangible assets, net
|
|
175,839
|
|
|
98,711
|
|
||
Deferred charges and other assets, net
|
|
327,868
|
|
|
176,625
|
|
||
Total other assets, net
|
|
2,061,875
|
|
|
390,029
|
|
||
Total assets
|
|
$
|
10,890,253
|
|
|
$
|
5,569,285
|
|
|
|
|
|
|
||||
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts and notes payable
|
|
$
|
496,259
|
|
|
$
|
235,329
|
|
Accrued liabilities
|
|
537,483
|
|
|
287,313
|
|
||
Term loan
|
|
149,341
|
|
|
—
|
|
||
Total current liabilities
|
|
1,183,083
|
|
|
522,642
|
|
||
Long-term debt, net
|
|
3,678,654
|
|
|
758,148
|
|
||
Deferred income taxes
|
|
1,650,575
|
|
|
575,603
|
|
||
Pension and other post-retirement benefits
|
|
364,819
|
|
|
122,821
|
|
||
Other liabilities
|
|
121,077
|
|
|
28,140
|
|
||
Total liabilities
|
|
6,998,208
|
|
|
2,007,354
|
|
||
Commitments and contingencies (Notes 9, 10 and 23)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares
issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and
134,663,244 shares issued at December 31, 2016 and 2015, respectively (Note 11) |
|
1,347
|
|
|
1,347
|
|
||
Common stock, held in treasury, at cost; 5,726,377 and 4,444,898 shares
at December 31, 2016 and 2015, respectively (Note 11) |
|
(319,339
|
)
|
|
(258,312
|
)
|
||
Additional paid-in capital
|
|
550,641
|
|
|
542,148
|
|
||
Retained earnings
|
|
3,412,286
|
|
|
3,109,987
|
|
||
Accumulated other comprehensive loss
|
|
(121,306
|
)
|
|
(129,292
|
)
|
||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,523,629
|
|
|
3,265,878
|
|
||
Noncontrolling interests
|
|
368,416
|
|
|
296,053
|
|
||
Total equity
|
|
3,892,045
|
|
|
3,561,931
|
|
||
Total liabilities and equity
|
|
$
|
10,890,253
|
|
|
$
|
5,569,285
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars,
except share amounts and per share data)
|
||||||||||
Net sales
|
|
$
|
5,075,456
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
Cost of sales
|
|
4,094,894
|
|
|
3,278,145
|
|
|
3,098,000
|
|
|||
Gross profit
|
|
980,562
|
|
|
1,185,191
|
|
|
1,317,350
|
|
|||
Selling, general and administrative expenses
|
|
295,436
|
|
|
225,364
|
|
|
183,745
|
|
|||
Transaction and integration-related costs
|
|
103,672
|
|
|
—
|
|
|
9,614
|
|
|||
Income from operations
|
|
581,454
|
|
|
959,827
|
|
|
1,123,991
|
|
|||
Other income (expense)
|
|
|
|
|
|
|
||||||
Interest expense
|
|
(79,473
|
)
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|||
Other income (expense), net
|
|
56,398
|
|
|
38,270
|
|
|
(2,721
|
)
|
|||
Income before income taxes
|
|
558,379
|
|
|
963,441
|
|
|
1,083,918
|
|
|||
Provision for income taxes
|
|
138,520
|
|
|
298,396
|
|
|
398,902
|
|
|||
Net income
|
|
419,859
|
|
|
665,045
|
|
|
685,016
|
|
|||
Net income attributable to noncontrolling interests
|
|
21,000
|
|
|
19,035
|
|
|
6,493
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
398,859
|
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
Earnings per common share attributable to
Westlake Chemical Corporation (Note 18):
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
Diluted
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
Weighted average shares outstanding (Note 18)
|
|
|
|
|
|
|
||||||
Basic
|
|
129,367,712
|
|
|
131,823,707
|
|
|
133,111,230
|
|
|||
Diluted
|
|
129,974,822
|
|
|
132,301,812
|
|
|
133,643,414
|
|
|||
Dividends per common share (Note 11)
|
|
$
|
0.7442
|
|
|
$
|
0.6930
|
|
|
$
|
0.5820
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars)
|
||||||||||
Net income
|
|
$
|
419,859
|
|
|
$
|
665,045
|
|
|
$
|
685,016
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
||||||
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
||||||
Pension and other post-retirement reserves adjustment
(excluding amortization)
|
|
59,546
|
|
|
18,260
|
|
|
(25,766
|
)
|
|||
Curtailment
|
|
364
|
|
|
—
|
|
|
—
|
|
|||
Settlement benefits
|
|
371
|
|
|
355
|
|
|
—
|
|
|||
Amortization of benefits liability
|
|
1,429
|
|
|
2,663
|
|
|
924
|
|
|||
Income tax (provision) benefit on pension and other
post-retirement benefits liability
|
|
(24,158
|
)
|
|
(6,443
|
)
|
|
8,096
|
|
|||
Foreign currency translation adjustments
|
|
(34,512
|
)
|
|
(59,466
|
)
|
|
(60,128
|
)
|
|||
Available-for-sale investments
|
|
|
|
|
|
|
||||||
Unrealized holding gains (losses) on investments
|
|
61,438
|
|
|
(4,362
|
)
|
|
1,301
|
|
|||
Reclassification of net realized gains to net income
|
|
(53,720
|
)
|
|
(3,798
|
)
|
|
(1,212
|
)
|
|||
Income tax benefit (provision) on available-for-sale investments
|
|
(2,772
|
)
|
|
2,932
|
|
|
(32
|
)
|
|||
Other comprehensive income (loss)
|
|
7,986
|
|
|
(49,859
|
)
|
|
(76,817
|
)
|
|||
Comprehensive income
|
|
427,845
|
|
|
615,186
|
|
|
608,199
|
|
|||
Comprehensive income attributable to noncontrolling interests,
net of tax of $279 for 2016 and $0 for 2015 and 2014
|
|
21,000
|
|
|
19,035
|
|
|
6,493
|
|
|||
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
406,845
|
|
|
$
|
596,151
|
|
|
$
|
601,706
|
|
|
|
Common Stock
|
|
Common Stock,
Held in Treasury
|
|
|
|
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
|
|
|
||||||||||||||||||||||||||||
|
|
Number of
Shares
|
|
Amount
|
|
Number of
Shares
|
|
At Cost
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net
Unrealized
Holding
Gains on
Investments,
Net of Tax
|
|
Noncontrolling Interests
|
|
Total
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
(in thousands of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||||||||||
Balances at December 31, 2013
|
|
134,580,208
|
|
|
$
|
1,346
|
|
|
1,252,922
|
|
|
$
|
(46,220
|
)
|
|
$
|
511,432
|
|
|
$
|
1,954,661
|
|
|
$
|
(6,696
|
)
|
|
$
|
3,904
|
|
|
$
|
176
|
|
|
$
|
—
|
|
|
$
|
2,418,603
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
678,523
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,493
|
|
|
685,016
|
|
|||||||||
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,746
|
)
|
|
(60,128
|
)
|
|
57
|
|
|
—
|
|
|
(76,817
|
)
|
|||||||||
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
671,791
|
|
|
(52,630
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,630
|
)
|
|||||||||
Shares issued—stock-
based compensation
|
|
98,856
|
|
|
1
|
|
|
(137,167
|
)
|
|
2,478
|
|
|
3,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,524
|
|
|||||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,964
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,964
|
|
|||||||||
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(77,656
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(77,656
|
)
|
|||||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,204
|
)
|
|
(2,204
|
)
|
|||||||||
Issuance of Westlake
Chemical Partners LP
common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
286,088
|
|
|||||||||
Balances at December 31, 2014
|
|
134,679,064
|
|
|
1,347
|
|
|
1,787,546
|
|
|
(96,372
|
)
|
|
530,441
|
|
|
2,555,528
|
|
|
(23,442
|
)
|
|
(56,224
|
)
|
|
233
|
|
|
290,377
|
|
|
3,201,888
|
|
|||||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
646,010
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,035
|
|
|
665,045
|
|
|||||||||
Other comprehensive
(loss) income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,835
|
|
|
(59,466
|
)
|
|
(5,228
|
)
|
|
—
|
|
|
(49,859
|
)
|
|||||||||
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
2,701,937
|
|
|
(163,138
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(163,138
|
)
|
|||||||||
Shares issued—stock-
based compensation
|
|
(15,820
|
)
|
|
—
|
|
|
(44,585
|
)
|
|
1,198
|
|
|
(135
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,063
|
|
|||||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,842
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,842
|
|
|||||||||
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
|||||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,956
|
)
|
|
(14,956
|
)
|
|||||||||
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,597
|
|
|
1,597
|
|
|||||||||
Balances at December 31, 2015
|
|
134,663,244
|
|
|
1,347
|
|
|
4,444,898
|
|
|
(258,312
|
)
|
|
542,148
|
|
|
3,109,987
|
|
|
(8,607
|
)
|
|
(115,690
|
)
|
|
(4,995
|
)
|
|
296,053
|
|
|
3,561,931
|
|
|||||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
398,859
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
21,000
|
|
|
419,859
|
|
|||||||||
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
37,552
|
|
|
(34,512
|
)
|
|
4,946
|
|
|
—
|
|
|
7,986
|
|
|||||||||
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
1,511,109
|
|
|
(66,727
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(66,727
|
)
|
|||||||||
Shares issued—stock-
based compensation
|
|
(11,864
|
)
|
|
—
|
|
|
(117,019
|
)
|
|
2,938
|
|
|
4,790
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,728
|
|
|||||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
(112,611
|
)
|
|
2,762
|
|
|
3,703
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,465
|
|
|||||||||
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(96,560
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(96,560
|
)
|
|||||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,637
|
)
|
|
(16,637
|
)
|
|||||||||
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
68,000
|
|
|
68,000
|
|
|||||||||
Balances at December 31, 2016
|
|
134,651,380
|
|
|
$
|
1,347
|
|
|
5,726,377
|
|
|
$
|
(319,339
|
)
|
|
$
|
550,641
|
|
|
$
|
3,412,286
|
|
|
$
|
28,945
|
|
|
$
|
(150,202
|
)
|
|
$
|
(49
|
)
|
|
$
|
368,416
|
|
|
$
|
3,892,045
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in thousands of dollars)
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
419,859
|
|
|
$
|
665,045
|
|
|
$
|
685,016
|
|
Adjustments to reconcile net income to net cash provided by
operating activities
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
377,666
|
|
|
245,757
|
|
|
208,486
|
|
|||
Provision for doubtful accounts
|
|
4,095
|
|
|
956
|
|
|
301
|
|
|||
Amortization of debt issuance costs
|
|
3,159
|
|
|
2,004
|
|
|
1,673
|
|
|||
Stock-based compensation expense
|
|
14,193
|
|
|
10,196
|
|
|
9,261
|
|
|||
Loss from disposition of property, plant and equipment
|
|
8,629
|
|
|
10,891
|
|
|
4,181
|
|
|||
Gains realized on previously held shares of Axiall common stock and
from sales of securities
|
|
(53,754
|
)
|
|
(3,798
|
)
|
|
(1,212
|
)
|
|||
Gain on acquisition, net of loss on the fair value remeasurement
of preexisting equity interest
|
|
—
|
|
|
(21,045
|
)
|
|
—
|
|
|||
Impairment of equity method investments
|
|
—
|
|
|
4,925
|
|
|
6,747
|
|
|||
Deferred income taxes
|
|
100,677
|
|
|
39,784
|
|
|
58,967
|
|
|||
Windfall tax benefits from share-based payment arrangements
|
|
(2,624
|
)
|
|
(1,646
|
)
|
|
(6,704
|
)
|
|||
Loss (income) from equity method investments, net of dividends
|
|
1,503
|
|
|
(632
|
)
|
|
(424
|
)
|
|||
Other (gains) losses, net
|
|
(1,050
|
)
|
|
362
|
|
|
1,487
|
|
|||
Changes in operating assets and liabilities, net of effect of business
acquisitions
|
|
|
|
|
|
|
||||||
Accounts receivable
|
|
50,291
|
|
|
62,722
|
|
|
33,161
|
|
|||
Inventories
|
|
(61,985
|
)
|
|
99,430
|
|
|
51,087
|
|
|||
Prepaid expenses and other current assets
|
|
11,370
|
|
|
(4,257
|
)
|
|
7,461
|
|
|||
Accounts payable
|
|
11,950
|
|
|
(21,604
|
)
|
|
(97,237
|
)
|
|||
Accrued liabilities
|
|
48,316
|
|
|
(7,640
|
)
|
|
74,989
|
|
|||
Other, net
|
|
(98,443
|
)
|
|
(2,614
|
)
|
|
(4,864
|
)
|
|||
Net cash provided by operating activities
|
|
833,852
|
|
|
1,078,836
|
|
|
1,032,376
|
|
|||
Cash flows from investing activities
|
|
|
|
|
|
|
||||||
Acquisition of business, net of cash acquired
|
|
(2,437,829
|
)
|
|
15,782
|
|
|
(611,087
|
)
|
|||
Additions to property, plant and equipment
|
|
(628,483
|
)
|
|
(491,426
|
)
|
|
(431,104
|
)
|
|||
Additions to cost method investment
|
|
(17,000
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from disposition of assets
|
|
1,207
|
|
|
49
|
|
|
181
|
|
|||
Proceeds from disposition of equity method investment
|
|
—
|
|
|
27,865
|
|
|
—
|
|
|||
Proceeds from repayment of loan acquired
|
|
—
|
|
|
—
|
|
|
45,923
|
|
|||
Proceeds from sales and maturities of securities
|
|
662,938
|
|
|
48,900
|
|
|
342,045
|
|
|||
Purchase of securities
|
|
(138,422
|
)
|
|
(605,098
|
)
|
|
(117,332
|
)
|
|||
Settlements of derivative instruments
|
|
(5,211
|
)
|
|
(2,248
|
)
|
|
(1,831
|
)
|
|||
Net cash used for investing activities
|
|
(2,562,800
|
)
|
|
(1,006,176
|
)
|
|
(773,205
|
)
|
|||
Cash flows from financing activities
|
|
|
|
|
|
|
||||||
Debt issuance costs
|
|
(35,773
|
)
|
|
—
|
|
|
(1,186
|
)
|
|||
Dividends paid
|
|
(96,560
|
)
|
|
(91,551
|
)
|
|
(77,656
|
)
|
|||
Distributions to noncontrolling interests
|
|
(16,637
|
)
|
|
(14,856
|
)
|
|
(2,204
|
)
|
|||
Proceeds from senior notes issuance
|
|
1,428,512
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from term loan and drawdown of revolver
|
|
600,000
|
|
|
—
|
|
|
—
|
|
|||
Net proceeds from WLKP LP common stock units
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|||
Proceeds from exercise of stock options
|
|
2,179
|
|
|
1,063
|
|
|
5,524
|
|
|||
Restricted cash associated with term loan
|
|
(154,000
|
)
|
|
—
|
|
|
—
|
|
|||
Repayment of revolver
|
|
(125,000
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from issuance of notes payable
|
|
8,324
|
|
|
52,960
|
|
|
—
|
|
|||
Repayment of notes payable
|
|
(13,046
|
)
|
|
(73,615
|
)
|
|
—
|
|
|||
Repurchase of common stock for treasury
|
|
(67,406
|
)
|
|
(162,459
|
)
|
|
(52,630
|
)
|
|||
Windfall tax benefits from share-based payment arrangements
|
|
2,624
|
|
|
1,646
|
|
|
6,704
|
|
|||
Net cash provided (used for) by financing activities
|
|
1,533,217
|
|
|
(286,812
|
)
|
|
164,640
|
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
|
(7,341
|
)
|
|
(3,924
|
)
|
|
(4,511
|
)
|
|||
Net (decrease) increase in cash and cash equivalents
|
|
(203,072
|
)
|
|
(218,076
|
)
|
|
419,300
|
|
|||
Cash and cash equivalents at beginning of the year
|
|
662,525
|
|
|
880,601
|
|
|
461,301
|
|
|||
Cash and cash equivalents at end of the year
|
|
$
|
459,453
|
|
|
$
|
662,525
|
|
|
$
|
880,601
|
|
Classification
|
|
Years
|
|
|
|
Buildings and improvements
|
25
|
|
Plant and equipment
|
25
|
|
Ethylene pipeline
|
35
|
|
Other
|
3-10
|
|
|
Year Ended December 31, 2016
|
||
Beginning balance, January 1,
|
|
$
|
—
|
|
Acquisitions
(1)
|
|
21,174
|
|
|
Accretion expense
|
|
251
|
|
|
Ending balance, December 31,
|
|
$
|
21,425
|
|
(1)
|
See Note 2, "Acquisitions" for additional information on the Company's acquisition activities.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Beginning balance, January 1,
|
|
$
|
2,879
|
|
|
$
|
1,833
|
|
|
$
|
1,219
|
|
Estimated fair value of warranty liability assumed in acquisition
(1)
|
|
14,564
|
|
|
—
|
|
|
612
|
|
|||
Warranty provisions
|
|
3,009
|
|
|
1,987
|
|
|
632
|
|
|||
Effects of changes in foreign exchange rates
|
|
(196
|
)
|
|
(97
|
)
|
|
(79
|
)
|
|||
Warranty claims paid
|
|
(3,186
|
)
|
|
(844
|
)
|
|
(551
|
)
|
|||
Ending balance, December 31,
|
|
$
|
17,070
|
|
|
$
|
2,879
|
|
|
$
|
1,833
|
|
(1)
|
See Note 2, "Acquisitions" for additional information on the Company's acquisition activities.
|
|
|
Pro Forma
|
||||||
|
|
Year Ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Net sales
|
|
$
|
7,080,545
|
|
|
$
|
7,793,086
|
|
|
|
|
|
|
||||
Net income
(1)
|
|
$
|
398,826
|
|
|
$
|
662,750
|
|
Net income (loss) attributable to noncontrolling interest
|
|
22,748
|
|
|
(1,665
|
)
|
||
Net income attributable to Westlake Chemical Corporation
(1)
|
|
$
|
376,078
|
|
|
$
|
664,415
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
||||
Basic
|
|
$
|
2.89
|
|
|
$
|
5.02
|
|
Diluted
|
|
$
|
2.88
|
|
|
$
|
5.00
|
|
(1)
|
The 2016 pro forma net income amounts include Axiall's historical pre-tax charges recorded during the eight-month period prior to the closing of the Merger for (1) divestitures; (2) restructuring; and (3) legal and settlement claims, net, of
$26,666
,
$22,881
and
$23,376
, respectively. These nonrecurring costs are included in the pro forma results because they were not directly attributable to the Merger.
|
|
|
Final Purchase Consideration as of August 31, 2016
|
||
Closing stock purchase:
|
|
|
||
Offer per share
|
|
$
|
33.00
|
|
Multiplied by number of shares outstanding at acquisition
|
|
67,277
|
|
|
Fair value of Axiall shares outstanding purchased by the Company
|
|
$
|
2,220,141
|
|
Plus:
|
|
|
||
Axiall debt repaid at acquisition
|
|
247,135
|
|
|
Seller's transaction costs paid by the Company
(1)
|
|
47,458
|
|
|
Total fair value of consideration transferred
|
|
$
|
2,514,734
|
|
|
|
|
||
Fair value of Axiall share-based awards attributed to pre-combination service
(2)
|
|
$
|
11,346
|
|
Additional settlement value of shares acquired
|
|
13,280
|
|
|
Purchase consideration
|
|
$
|
2,539,360
|
|
|
|
|
||
Fair value of previously held equity interest in Axiall
(3)
|
|
102,300
|
|
|
Total fair value allocated to net assets acquired
|
|
$
|
2,641,660
|
|
(1)
|
Transactions costs incurred by the seller included legal and advisory costs incurred for the benefit of Axiall's former shareholders and board of directors to evaluate the Company's initial Merger proposals, explore strategic alternatives and negotiate the purchase price.
|
(2)
|
The fair value of share-based awards attributable to pre-combination service includes the ratio of the pre-combination service performed to the original service period of the Axiall restricted share units and options, including related dividend equivalent rights.
|
(3)
|
Prior to the Merger, the Company owned
3.1 million
shares in Axiall. The investment in Axiall was carried at estimated fair value with unrealized gains recorded as a component of accumulated other comprehensive loss on the consolidated balance sheet. The Company recognized a
$49,080
gain for the investment in other income, net in the consolidated statement of operations upon gaining control.
|
Cash
|
|
$
|
88,251
|
|
Accounts receivable
(1)
|
|
422,459
|
|
|
Income tax receivable
|
|
55,193
|
|
|
Inventories
|
|
306,158
|
|
|
Prepaid expenses and other current assets
|
|
55,462
|
|
|
Property, plant and equipment
(2)
|
|
3,134,741
|
|
|
Customer relationships (weighted average lives of 10.7 years)
(3)
|
|
590,000
|
|
|
Other intangible assets:
|
|
|
||
Trade name (weighted average lives of 6.8 years)
|
|
50,000
|
|
|
Technology (weighted average lives of 5.4 years)
|
|
41,500
|
|
|
Supply contracts and leases (weighted average lives of 6.3 years)
|
|
27,288
|
|
|
Other assets
|
|
98,708
|
|
|
Total assets acquired
|
|
$
|
4,869,760
|
|
Accounts and notes payable
|
|
255,232
|
|
|
Interest payable
|
|
8,154
|
|
|
Income tax payable
|
|
967
|
|
|
Accrued compensation
|
|
44,186
|
|
|
Accrued liabilities
|
|
152,550
|
|
|
Deferred income taxes
|
|
985,128
|
|
|
Tax reserve non-current
|
|
3,130
|
|
|
Pension and other post-retirement obligations
|
|
311,106
|
|
|
Other liabilities
|
|
99,848
|
|
|
Long-term debt
|
|
1,187,290
|
|
|
Total liabilities assumed
|
|
$
|
3,047,591
|
|
Total identifiable net assets acquired
|
|
$
|
1,822,169
|
|
Noncontrolling interest
|
|
(68,000
|
)
|
|
Goodwill
|
|
887,491
|
|
|
Total fair value allocated to net assets acquired
|
|
$
|
2,641,660
|
|
(1)
|
The fair value of accounts receivable acquired is
$422,459
, with the gross contractual amount being
$434,834
. The Company expects
$12,375
to be uncollectible.
|
(2)
|
The Company obtained additional information related to its property plant and equipment balances which led to a decrease in property plant and equipment of
$54,841
and a corresponding increase in goodwill.
|
(3)
|
The Company obtained additional information related to its customer relationship balances which led to an increase in customer relationship of
$30,000
and a corresponding decrease in goodwill.
|
|
December 31,
2015
|
||
Current
|
$
|
520,144
|
|
Non-current
|
48,081
|
|
|
Total available-for-sale securities
|
$
|
568,225
|
|
|
|
December 31, 2015
|
||||||||||||||
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
Corporate bonds
|
|
$
|
336,665
|
|
|
$
|
55
|
|
|
$
|
(1,076
|
)
|
|
$
|
335,644
|
|
U.S. government debt
(2)
|
|
135,226
|
|
|
2
|
|
|
(374
|
)
|
|
134,854
|
|
||||
Asset-backed securities
|
|
49,759
|
|
|
2
|
|
|
(115
|
)
|
|
49,646
|
|
||||
Equity securities
|
|
$
|
54,371
|
|
|
$
|
466
|
|
|
$
|
(6,756
|
)
|
|
$
|
48,081
|
|
Total available-for-sale securities
|
|
$
|
576,021
|
|
|
$
|
525
|
|
|
$
|
(8,321
|
)
|
|
$
|
568,225
|
|
(1)
|
All unrealized loss positions were held at a loss for less than 12 months.
|
(2)
|
U.S. Treasury obligations, U.S. government agency obligations and U.S government agency mortgage-backed securities.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Proceeds from sales and maturities of securities
|
|
$
|
662,938
|
|
|
$
|
48,900
|
|
|
$
|
342,045
|
|
Gross realized gains
|
|
53,754
|
|
|
3,830
|
|
|
1,311
|
|
|||
Gross realized losses
|
|
(35
|
)
|
|
(32
|
)
|
|
(99
|
)
|
|
|
2016
|
|
2015
|
||||
Trade customers
|
|
$
|
827,721
|
|
|
$
|
438,538
|
|
Allowance for doubtful accounts
|
|
(17,991
|
)
|
|
(14,095
|
)
|
||
|
|
809,730
|
|
|
424,443
|
|
||
Federal and state taxes
|
|
90,414
|
|
|
60,748
|
|
||
Other
|
|
38,599
|
|
|
23,341
|
|
||
Accounts receivable, net
|
|
$
|
938,743
|
|
|
$
|
508,532
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Balance at Beginning of Year, January 1
|
|
$
|
14,095
|
|
|
$
|
13,468
|
|
|
$
|
11,741
|
|
Charged to Expense
|
|
4,095
|
|
|
956
|
|
|
301
|
|
|||
Additions/(Deductions)
(1)
|
|
(199
|
)
|
|
(329
|
)
|
|
1,426
|
|
|||
Balance at End of Year, December 31
|
|
$
|
17,991
|
|
|
$
|
14,095
|
|
|
$
|
13,468
|
|
(1)
|
Deductions primarily represent accounts receivable written off during the period.
|
|
|
2016
|
|
2015
|
||||
Finished products
|
|
$
|
500,861
|
|
|
$
|
253,338
|
|
Feedstock, additives and chemicals
|
|
216,877
|
|
|
106,435
|
|
||
Materials and supplies
|
|
83,362
|
|
|
74,287
|
|
||
Inventories
|
|
$
|
801,100
|
|
|
$
|
434,060
|
|
|
|
2016
|
|
2015
|
||||
Land
|
|
$
|
194,137
|
|
|
$
|
33,051
|
|
Building and improvements
|
|
464,570
|
|
|
266,214
|
|
||
Plant and equipment
|
|
6,913,721
|
|
|
3,632,416
|
|
||
Other
|
|
377,466
|
|
|
241,829
|
|
||
|
|
7,949,894
|
|
|
4,173,510
|
|
||
Less: Accumulated depreciation
|
|
(1,919,229
|
)
|
|
(1,685,255
|
)
|
||
|
|
6,030,665
|
|
|
2,488,255
|
|
||
Construction in progress
|
|
389,397
|
|
|
515,812
|
|
||
Property, plant and equipment, net
|
|
$
|
6,420,062
|
|
|
$
|
3,004,067
|
|
|
|
2016
|
|
2015
|
|
Weighted
Average
Life
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
|||||||||||||
Goodwill
|
|
$
|
946,553
|
|
|
$
|
—
|
|
|
$
|
946,553
|
|
|
$
|
62,016
|
|
|
$
|
—
|
|
|
$
|
62,016
|
|
|
|
Customer relationships
|
|
662,080
|
|
|
(50,465
|
)
|
|
611,615
|
|
|
75,249
|
|
|
(22,572
|
)
|
|
52,677
|
|
|
10
|
||||||
Other intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Licenses and intellectual
property
|
|
120,992
|
|
|
(44,035
|
)
|
|
76,957
|
|
|
79,699
|
|
|
(38,643
|
)
|
|
41,056
|
|
|
13
|
||||||
Trademarks
|
|
87,927
|
|
|
(6,841
|
)
|
|
81,086
|
|
|
39,085
|
|
|
(2,602
|
)
|
|
36,483
|
|
|
12
|
||||||
Other
|
|
31,038
|
|
|
(13,242
|
)
|
|
17,796
|
|
|
29,320
|
|
|
(8,148
|
)
|
|
21,172
|
|
|
11
|
||||||
Total other intangible assets
|
|
239,957
|
|
|
(64,118
|
)
|
|
175,839
|
|
|
148,104
|
|
|
(49,393
|
)
|
|
98,711
|
|
|
|
||||||
Deferred charges and
other assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost-method investments
|
|
108,938
|
|
|
—
|
|
|
108,938
|
|
|
51,334
|
|
|
—
|
|
|
51,334
|
|
|
|
||||||
Equity-method
investments
|
|
21,522
|
|
|
—
|
|
|
21,522
|
|
|
9,208
|
|
|
—
|
|
|
9,208
|
|
|
|
||||||
Restricted cash
|
|
25,689
|
|
|
—
|
|
|
25,689
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
||||||
Turnaround costs
|
|
168,501
|
|
|
(74,671
|
)
|
|
93,830
|
|
|
111,078
|
|
|
(74,943
|
)
|
|
36,135
|
|
|
5
|
||||||
Deferred Taxes
|
|
12,526
|
|
|
—
|
|
|
12,526
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
||||||
Debt issuance costs
|
|
3,055
|
|
|
(210
|
)
|
|
2,845
|
|
|
11,915
|
|
|
(10,762
|
)
|
|
1,153
|
|
|
5
|
||||||
Other
|
|
82,287
|
|
|
(19,769
|
)
|
|
62,518
|
|
|
99,763
|
|
|
(20,968
|
)
|
|
78,795
|
|
|
8
|
||||||
Total deferred charges and
other assets
|
|
422,518
|
|
|
(94,650
|
)
|
|
327,868
|
|
|
283,298
|
|
|
(106,673
|
)
|
|
176,625
|
|
|
|
||||||
Other assets, net
|
|
$
|
2,271,108
|
|
|
$
|
(209,233
|
)
|
|
$
|
2,061,875
|
|
|
$
|
568,667
|
|
|
$
|
(178,638
|
)
|
|
$
|
390,029
|
|
|
|
|
|
Olefins Segment
|
|
Vinyls Segment
|
|
Total
|
||||||
Balance at December 31, 2014
|
|
$
|
29,990
|
|
|
$
|
32,026
|
|
|
$
|
62,016
|
|
Balance at December 31, 2015
|
|
29,990
|
|
|
32,026
|
|
|
62,016
|
|
|||
Goodwill acquired during the year
|
|
—
|
|
|
887,491
|
|
|
887,491
|
|
|||
Effects of changes in foreign exchange rates
|
|
—
|
|
|
(2,954
|
)
|
|
(2,954
|
)
|
|||
Balance at December 31, 2016
|
|
$
|
29,990
|
|
|
$
|
916,563
|
|
|
$
|
946,553
|
|
|
|
2016
|
|
2015
|
||||
Accounts payable
|
|
$
|
494,743
|
|
|
$
|
229,219
|
|
Notes payable to banks
|
|
1,516
|
|
|
6,110
|
|
||
Accounts and notes payable
|
|
$
|
496,259
|
|
|
$
|
235,329
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Principal Amount
|
|
Unamortized Premium, Discount and Debt Issuance Costs
(1)
|
|
Net Long-Term Debt
|
|
Principal Amount
|
|
Unamortized Discount and Debt Issuance Costs
(1)
|
|
Net Long-Term Debt
|
||||||||||||
Revolving credit facility
|
|
$
|
325,000
|
|
|
$
|
—
|
|
|
$
|
325,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
4.625% senior notes due 2021 (the
"4.625% Westlake 2021 Senior Notes")
|
|
624,793
|
|
|
26,837
|
|
|
651,630
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
4.625% senior notes due 2021
(the "4.625% Subsidiary 2021 Senior
Notes")
|
|
63,207
|
|
|
2,862
|
|
|
66,069
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
3.60% senior notes due 2022
|
|
250,000
|
|
|
(1,891
|
)
|
|
248,109
|
|
|
250,000
|
|
|
(2,232
|
)
|
|
247,768
|
|
||||||
4.875% senior notes due 2023 (the
"4.875% Westlake 2023 Senior Notes")
|
|
433,793
|
|
|
13,431
|
|
|
447,224
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
4.875% senior notes due 2023
(the "4.875% Subsidiary 2023 Senior
Notes")
|
|
16,207
|
|
|
540
|
|
|
16,747
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
3.60% senior notes due 2026
(the "3.60% 2026 Senior Notes")
|
|
750,000
|
|
|
(10,757
|
)
|
|
739,243
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Loan related to tax-exempt waste disposal
revenue bonds due 2027
|
|
10,889
|
|
|
—
|
|
|
10,889
|
|
|
10,889
|
|
|
—
|
|
|
10,889
|
|
||||||
6 ½% senior notes due 2029
|
|
100,000
|
|
|
(916
|
)
|
|
99,084
|
|
|
100,000
|
|
|
(989
|
)
|
|
99,011
|
|
||||||
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
(1,883
|
)
|
|
248,117
|
|
|
250,000
|
|
|
(2,002
|
)
|
|
247,998
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
2035 GO Zone Senior Notes") |
|
89,000
|
|
|
(839
|
)
|
|
88,161
|
|
|
89,000
|
|
|
(884
|
)
|
|
88,116
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
2035 IKE Zone Senior Notes") |
|
65,000
|
|
|
(602
|
)
|
|
64,398
|
|
|
65,000
|
|
|
(634
|
)
|
|
64,366
|
|
||||||
5.0% senior notes due 2046 (the "5.0%
2046 Senior Notes")
|
|
700,000
|
|
|
(26,017
|
)
|
|
673,983
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Long-term debt, net
|
|
$
|
3,677,889
|
|
|
$
|
765
|
|
|
$
|
3,678,654
|
|
|
$
|
764,889
|
|
|
$
|
(6,741
|
)
|
|
$
|
758,148
|
|
(1)
|
Includes unamortized debt issuance costs of
$24,113
and
$5,967
at
December 31, 2016
and
December 31, 2015
, respectively.
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
Balances at December 31, 2014
|
|
$
|
(23,442
|
)
|
|
$
|
(56,224
|
)
|
|
$
|
233
|
|
|
$
|
(79,433
|
)
|
Other comprehensive income (loss) before
reclassifications
|
|
12,877
|
|
|
(59,466
|
)
|
|
(2,795
|
)
|
|
(49,384
|
)
|
||||
Amounts reclassified from accumulated other
comprehensive loss
|
|
1,958
|
|
|
—
|
|
|
(2,433
|
)
|
|
(475
|
)
|
||||
Net other comprehensive income (loss) for the year
|
|
14,835
|
|
|
(59,466
|
)
|
|
(5,228
|
)
|
|
(49,859
|
)
|
||||
Balances at December 31, 2015
|
|
(8,607
|
)
|
|
(115,690
|
)
|
|
(4,995
|
)
|
|
(129,292
|
)
|
||||
Other comprehensive income (loss) before
reclassifications
|
|
36,211
|
|
|
(34,512
|
)
|
|
57,004
|
|
|
58,703
|
|
||||
Amounts reclassified from accumulated other
comprehensive loss
|
|
1,341
|
|
|
—
|
|
|
(52,058
|
)
|
|
(50,717
|
)
|
||||
Net other comprehensive income (loss) for the year
|
|
37,552
|
|
|
(34,512
|
)
|
|
4,946
|
|
|
7,986
|
|
||||
Balances at December 31, 2016
|
|
$
|
28,945
|
|
|
$
|
(150,202
|
)
|
|
$
|
(49
|
)
|
|
$
|
(121,306
|
)
|
Details about Accumulated Other
Comprehensive Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Year Ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
|||||||||
Amortization of pension and other
post-retirement items
|
|
|
|
|
|
|
|
|
||||||
Prior service costs
|
|
(1)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(347
|
)
|
Net loss
|
|
(1)
|
|
(1,429
|
)
|
|
(2,663
|
)
|
|
(577
|
)
|
|||
Curtailment
|
|
(1)
|
|
(364
|
)
|
|
—
|
|
|
—
|
|
|||
Settlement benefits
|
|
(1)
|
|
(371
|
)
|
|
(355
|
)
|
|
—
|
|
|||
|
|
|
|
(2,164
|
)
|
|
(3,018
|
)
|
|
(924
|
)
|
|||
|
|
Provision for income taxes
|
|
823
|
|
|
1,060
|
|
|
356
|
|
|||
|
|
|
|
(1,341
|
)
|
|
(1,958
|
)
|
|
(568
|
)
|
|||
Net unrealized gains on available-for-
sale investments
|
|
|
|
|
|
|
|
|
||||||
Realized gain on available-
for-sale investments
|
|
Other income, net
|
|
53,720
|
|
|
3,798
|
|
|
1,212
|
|
|||
|
|
Provision for income taxes
|
|
(1,662
|
)
|
|
(1,365
|
)
|
|
(435
|
)
|
|||
|
|
|
|
52,058
|
|
|
2,433
|
|
|
777
|
|
|||
Total reclassifications for the period
|
|
|
|
$
|
50,717
|
|
|
$
|
475
|
|
|
$
|
209
|
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, see Note 13.
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, beginning of year
|
|
$
|
62,192
|
|
|
$
|
94,821
|
|
|
$
|
67,010
|
|
|
$
|
122,701
|
|
Benefit obligation assumed with acquisition
|
|
818,602
|
|
|
20,895
|
|
|
—
|
|
|
—
|
|
||||
Service cost
|
|
975
|
|
|
1,459
|
|
|
29
|
|
|
1,661
|
|
||||
Interest cost
|
|
8,832
|
|
|
2,441
|
|
|
2,015
|
|
|
2,110
|
|
||||
Actuarial (gain) loss
|
|
(74,262
|
)
|
|
12,705
|
|
|
(2,330
|
)
|
|
(17,310
|
)
|
||||
Benefits paid
|
|
(17,081
|
)
|
|
(2,571
|
)
|
|
(4,532
|
)
|
|
(2,139
|
)
|
||||
Other
|
|
—
|
|
|
(61
|
)
|
|
—
|
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
(4,537
|
)
|
|
—
|
|
|
(12,202
|
)
|
||||
Benefit obligation, end of year
|
|
$
|
799,258
|
|
|
$
|
125,152
|
|
|
$
|
62,192
|
|
|
$
|
94,821
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year
|
|
$
|
50,763
|
|
|
$
|
—
|
|
|
$
|
53,415
|
|
|
$
|
—
|
|
Acquisition
|
|
575,865
|
|
|
16,298
|
|
|
—
|
|
|
—
|
|
||||
Actual return
|
|
7,334
|
|
|
27
|
|
|
(268
|
)
|
|
—
|
|
||||
Employer contribution
|
|
456
|
|
|
2,609
|
|
|
2,148
|
|
|
2,139
|
|
||||
Benefits paid
|
|
(17,081
|
)
|
|
(2,571
|
)
|
|
(4,532
|
)
|
|
(2,139
|
)
|
||||
Experience gain
|
|
136
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Administrative expenses paid
|
|
(3,204
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
(371
|
)
|
|
—
|
|
|
—
|
|
||||
Fair value of plan assets, end of year
|
|
$
|
614,269
|
|
|
$
|
15,992
|
|
|
$
|
50,763
|
|
|
$
|
—
|
|
Funded status, end of year
|
|
$
|
(184,989
|
)
|
|
$
|
(109,160
|
)
|
|
$
|
(11,429
|
)
|
|
$
|
(94,821
|
)
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in the consolidated
balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
Noncurrent assets
|
|
$
|
—
|
|
|
$
|
233
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Current liabilities
|
|
(1,691
|
)
|
|
(2,583
|
)
|
|
—
|
|
|
—
|
|
||||
Noncurrent liabilities
|
|
(183,298
|
)
|
|
(106,810
|
)
|
|
(11,429
|
)
|
|
(94,821
|
)
|
||||
Net amount recognized
|
|
$
|
(184,989
|
)
|
|
$
|
(109,160
|
)
|
|
$
|
(11,429
|
)
|
|
$
|
(94,821
|
)
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in accumulated other
comprehensive income
|
|
|
|
|
|
|
|
|
||||||||
Net (gain) loss
|
|
$
|
(53,302
|
)
|
|
$
|
7,990
|
|
|
$
|
14,755
|
|
|
$
|
(4,919
|
)
|
Foreign exchange effects
|
|
—
|
|
|
(15
|
)
|
|
—
|
|
|
1,986
|
|
||||
Total before tax
(1)
|
|
$
|
(53,302
|
)
|
|
$
|
7,975
|
|
|
$
|
14,755
|
|
|
$
|
(2,933
|
)
|
(1)
|
After-tax totals for pension benefits were
$30,287
and
$6,812
for
2016
and
2015
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive loss.
|
|
|
2016
|
|
2015
|
||||||||||||
Information for pension plans with an accumulated
benefit obligation in excess of plan assets
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Projected benefit obligation
|
|
$
|
(799,258
|
)
|
|
$
|
(113,286
|
)
|
|
$
|
(62,192
|
)
|
|
$
|
(94,821
|
)
|
Accumulated benefit obligation
|
|
(799,258
|
)
|
|
(109,837
|
)
|
|
(62,192
|
)
|
|
(93,231
|
)
|
||||
Fair value of plan assets
|
|
614,269
|
|
|
4,627
|
|
|
50,763
|
|
|
—
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Service cost
|
|
$
|
1,261
|
|
|
$
|
1,459
|
|
|
$
|
29
|
|
|
$
|
1,661
|
|
|
$
|
334
|
|
|
$
|
602
|
|
Administrative expenses
|
|
2,919
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Interest cost
|
|
8,832
|
|
|
2,441
|
|
|
2,015
|
|
|
2,110
|
|
|
2,322
|
|
|
1,366
|
|
||||||
Expected return on plan assets
|
|
(15,354
|
)
|
|
(199
|
)
|
|
(2,960
|
)
|
|
—
|
|
|
(3,140
|
)
|
|
—
|
|
||||||
Net amortization
|
|
1,307
|
|
|
—
|
|
|
1,270
|
|
|
1,048
|
|
|
571
|
|
|
—
|
|
||||||
Settlement benefits
|
|
371
|
|
|
—
|
|
|
355
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Net periodic benefit (gain) cost
|
|
$
|
(664
|
)
|
|
$
|
3,701
|
|
|
$
|
709
|
|
|
$
|
4,819
|
|
|
$
|
87
|
|
|
$
|
1,968
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other changes in plan assets and benefit
obligation recognized in other
comprehensive income (OCI)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net loss (gain) emerging
|
|
$
|
(66,379
|
)
|
|
$
|
12,893
|
|
|
$
|
898
|
|
|
$
|
(17,310
|
)
|
|
$
|
9,352
|
|
|
$
|
15,425
|
|
Amortization of net loss
|
|
(1,307
|
)
|
|
—
|
|
|
(1,270
|
)
|
|
(1,048
|
)
|
|
(274
|
)
|
|
—
|
|
||||||
Amortization of prior service cost
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(297
|
)
|
|
—
|
|
||||||
Settlement benefits
|
|
(371
|
)
|
|
—
|
|
|
(355
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total recognized in OCI
|
|
$
|
(68,057
|
)
|
|
$
|
12,893
|
|
|
$
|
(727
|
)
|
|
$
|
(18,358
|
)
|
|
$
|
8,781
|
|
|
$
|
15,425
|
|
Total net periodic benefit cost and OCI
|
|
$
|
(68,721
|
)
|
|
$
|
16,594
|
|
|
$
|
(18
|
)
|
|
$
|
(13,539
|
)
|
|
$
|
8,868
|
|
|
$
|
17,393
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Weighted average assumptions used to
determine benefit obligations at
December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate
|
|
3.8
|
%
|
|
1.8
|
%
|
|
4.0
|
%
|
|
2.4
|
%
|
|
3.5
|
%
|
|
1.9
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
—
|
%
|
|
2.5
|
%
|
Weighted average assumptions used to
determine net periodic benefit costs for
years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate for benefit obligations
|
|
3.2
|
%
|
|
2.4
|
%
|
|
3.5
|
%
|
|
1.9
|
%
|
|
4.5
|
%
|
|
2.6
|
%
|
Discount rate for service cost
|
|
3.4
|
%
|
|
2.4
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
Discount rate for interest cost
|
|
2.9
|
%
|
|
2.4
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
Expected return on plan assets
|
|
6.8
|
%
|
|
4.6
|
%
|
|
7.0
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
—
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
|
2016
|
|
2015
|
||||||||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non U.S. Plans
|
|
U.S. Plans
|
||||||||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 2
|
|
Total
|
||||||||||||||||
Cash and common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Cash and cash
equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,627
|
|
|
$
|
—
|
|
|
$
|
4,627
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Common stock
|
|
16,546
|
|
|
—
|
|
|
16,546
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Bank collective trust and
mutual funds—Equity
securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Large-cap funds
(1)
|
|
50,143
|
|
|
166,604
|
|
|
216,747
|
|
|
—
|
|
|
1,609
|
|
|
1,609
|
|
|
18,384
|
|
|
18,384
|
|
||||||||
Small-cap funds
(2)
|
|
8,379
|
|
|
23,407
|
|
|
31,786
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,069
|
|
|
4,069
|
|
||||||||
International funds
(3)
|
|
53,422
|
|
|
53,629
|
|
|
107,051
|
|
|
—
|
|
|
4,370
|
|
|
4,370
|
|
|
8,181
|
|
|
8,181
|
|
||||||||
Bank collective trust funds—Fixed income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Bond funds
(4)
|
|
61,778
|
|
|
165,657
|
|
|
227,435
|
|
|
—
|
|
|
5,386
|
|
|
5,386
|
|
|
19,624
|
|
|
19,624
|
|
||||||||
Short-term investment
funds
|
|
—
|
|
|
14,704
|
|
|
14,704
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
505
|
|
|
505
|
|
||||||||
|
|
$
|
190,268
|
|
|
$
|
424,001
|
|
|
$
|
614,269
|
|
|
$
|
4,627
|
|
|
$
|
11,365
|
|
|
$
|
15,992
|
|
|
$
|
50,763
|
|
|
$
|
50,763
|
|
(1)
|
Substantially all of the assets of these funds are invested in large-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(2)
|
Substantially all of the assets of these funds are invested in small-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(3)
|
Substantially all of the assets of these funds are invested in international companies in developed markets (excluding the United States). The remainder of the assets of these funds is invested in cash reserves.
|
(4)
|
This category represents investment grade bonds of U.S. issuers, including U.S. Treasury notes.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Contributions to multi-employer plans
(1)
|
|
$
|
4,952
|
|
|
$
|
4,489
|
|
|
$
|
2,295
|
|
(1)
|
The plan information for both the Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG plans is publicly available. The plans provide fixed, monthly retirement payments on the basis of the credits earned by the participating employees. To the extent that the plans are underfunded, future contributions to the plans may increase and may be used to fund retirement benefits for employees related to other employers. The Company does not consider either of its multi-employer plans individually significant.
|
|
|
2016
|
|
2015
|
||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
||||||
Change in benefit obligation
|
|
|
|
|
|
|
||||||
Benefit obligation, beginning of year
|
|
$
|
17,815
|
|
|
$
|
—
|
|
|
$
|
20,177
|
|
Benefit obligation assumed with acquisition
|
|
69,650
|
|
|
3,324
|
|
|
—
|
|
|||
Service cost
|
|
289
|
|
|
5
|
|
|
22
|
|
|||
Interest cost
|
|
1,000
|
|
|
12
|
|
|
571
|
|
|||
Actuarial (gain) loss
|
|
(6,151
|
)
|
|
91
|
|
|
(1,848
|
)
|
|||
Benefits paid
|
|
(2,355
|
)
|
|
(9
|
)
|
|
(1,107
|
)
|
|||
Curtailment
|
|
(364
|
)
|
|
—
|
|
|
—
|
|
|||
Plan participants' contributions
|
|
35
|
|
|
—
|
|
|
—
|
|
|||
Foreign exchange effects
|
|
—
|
|
|
(82
|
)
|
|
—
|
|
|||
Benefit obligation, end of year
|
|
$
|
79,919
|
|
|
$
|
3,341
|
|
|
$
|
17,815
|
|
|
|
|
|
|
|
|
||||||
Change in plan assets
|
|
|
|
|
|
|
||||||
Fair value of plan assets, beginning of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Employer contribution
|
|
2,320
|
|
|
9
|
|
|
1,107
|
|
|||
Plan participants' contributions
|
|
35
|
|
|
—
|
|
|
—
|
|
|||
Benefits paid
|
|
(2,355
|
)
|
|
(9
|
)
|
|
(1,107
|
)
|
|||
Fair value of plan assets, end of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Funded status, end of year
|
|
$
|
(79,919
|
)
|
|
$
|
(3,341
|
)
|
|
$
|
(17,815
|
)
|
|
|
2016
|
|
2015
|
||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
||||||
Amounts recognized in the consolidated balance sheet at December 31
|
|
|
|
|
|
|
||||||
Current liabilities
|
|
$
|
(8,447
|
)
|
|
$
|
(102
|
)
|
|
$
|
(1,244
|
)
|
Noncurrent liabilities
|
|
(71,472
|
)
|
|
(3,239
|
)
|
|
(16,571
|
)
|
|||
Net amount recognized
|
|
$
|
(79,919
|
)
|
|
$
|
(3,341
|
)
|
|
$
|
(17,815
|
)
|
|
|
2016
|
|
2015
|
||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
||||||
Amounts recognized in accumulated other comprehensive income
|
|
|
|
|
|
|
||||||
Net loss
|
|
$
|
(3,659
|
)
|
|
$
|
91
|
|
|
$
|
2,978
|
|
Total before tax
(1)
|
|
$
|
(3,659
|
)
|
|
$
|
91
|
|
|
$
|
2,978
|
|
(1)
|
After-tax totals for post-retirement healthcare benefits were a loss of
$1,342
and a gain of
$1,795
for
2016
and
2015
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive loss.
|
|
|
Year Ended December 31,
|
||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
||||||||
Service cost
|
|
$
|
289
|
|
|
$
|
5
|
|
|
$
|
22
|
|
|
$
|
22
|
|
Interest cost
|
|
1,000
|
|
|
12
|
|
|
571
|
|
|
733
|
|
||||
Net amortization
|
|
122
|
|
|
—
|
|
|
345
|
|
|
353
|
|
||||
Net periodic benefit cost
|
|
$
|
1,411
|
|
|
$
|
17
|
|
|
$
|
938
|
|
|
$
|
1,108
|
|
|
|
|
|
|
|
|
|
|
||||||||
Other changes in plan assets and benefit obligation recognized in other comprehensive income (OCI)
|
|
|
|
|
|
|
|
|
||||||||
Net (gain) loss emerging
|
|
$
|
(6,151
|
)
|
|
$
|
91
|
|
|
$
|
(1,848
|
)
|
|
$
|
989
|
|
Curtailment
|
|
(364
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Amortization of net loss
|
|
(122
|
)
|
|
—
|
|
|
(345
|
)
|
|
(303
|
)
|
||||
Amortization of prior service cost
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(50
|
)
|
||||
Total recognized in OCI
|
|
$
|
(6,637
|
)
|
|
$
|
91
|
|
|
$
|
(2,193
|
)
|
|
$
|
636
|
|
Total net periodic benefit cost and OCI
|
|
$
|
(5,226
|
)
|
|
$
|
108
|
|
|
$
|
(1,255
|
)
|
|
$
|
1,744
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
||||
Weighted average assumptions used to determine benefit obligations at December 31
|
|
|
|
|
|
|
|
|
||||
Discount rate
|
|
3.3
|
%
|
|
4.0
|
%
|
|
3.5
|
%
|
|
3.3
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
||||
- Initial rate
|
|
7.3
|
%
|
|
6.2
|
%
|
|
—
|
%
|
|
—
|
%
|
- Ultimate rate
|
|
4.5
|
%
|
|
4.5
|
%
|
|
—
|
%
|
|
—
|
%
|
- Years to ultimate
|
|
11
|
|
|
12
|
|
|
—
|
|
|
—
|
|
Weighted average assumptions used to determine net periodic benefit costs for years ended December 31
|
|
|
|
|
|
|
|
|
||||
Discount rate for benefit obligations
|
|
2.6
|
%
|
|
3.3
|
%
|
|
3.3
|
%
|
|
4.0
|
%
|
Discount rate for service cost
|
|
3.1
|
%
|
|
3.3
|
%
|
|
—
|
%
|
|
—
|
%
|
Discount rate for interest cost
|
|
2.8
|
%
|
|
3.3
|
%
|
|
—
|
%
|
|
—
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
||||
- Initial rate
|
|
7.0
|
%
|
|
6.8
|
%
|
|
—
|
%
|
|
—
|
%
|
- Ultimate rate
|
|
4.5
|
%
|
|
4.5
|
%
|
|
—
|
%
|
|
—
|
%
|
- Years to ultimate
|
|
12
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
|
Pension
Benefits
|
|
Post-
retirement
Healthcare
|
||||
Estimated future benefit payments:
|
|
|
|
|
||||
Year 1
|
|
$
|
51,324
|
|
|
$
|
8,663
|
|
Year 2
|
|
49,626
|
|
|
8,460
|
|
||
Year 3
|
|
51,163
|
|
|
8,302
|
|
||
Year 4
|
|
51,554
|
|
|
8,185
|
|
||
Year 5
|
|
51,715
|
|
|
8,122
|
|
||
Years 6 to 10
|
|
267,024
|
|
|
34,681
|
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Term
(Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding at December 31, 2015
|
|
1,267,790
|
|
|
$
|
30.07
|
|
|
|
|
|
||
Granted
|
|
292,448
|
|
|
44.42
|
|
|
|
|
|
|||
Exercised
|
|
(112,611
|
)
|
|
19.33
|
|
|
|
|
|
|||
Cancelled
|
|
(42,893
|
)
|
|
35.07
|
|
|
|
|
|
|||
Outstanding at December 31, 2016
|
|
1,404,734
|
|
|
$
|
33.76
|
|
|
5.3
|
|
$
|
34,368
|
|
Exercisable at December 31, 2016
|
|
940,314
|
|
|
$
|
24.29
|
|
|
3.7
|
|
$
|
31,009
|
|
Range of Prices
|
|
Options
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
$7.12 - $9.65
|
|
304,200
|
|
|
1.7
|
$10.26 - $18.05
|
|
235,916
|
|
|
2.3
|
$22.92 - $30.05
|
|
174,082
|
|
|
4.7
|
$40.38 - $52.35
|
|
391,083
|
|
|
8.4
|
$63.98 - $68.18
|
|
299,453
|
|
|
7.7
|
|
|
Stock Option Grants
|
||||||||||
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Weighted average fair value
|
|
$
|
11.67
|
|
|
$
|
20.21
|
|
|
$
|
20.49
|
|
Risk-free interest rate
|
|
1.4
|
%
|
|
1.7
|
%
|
|
1.6
|
%
|
|||
Expected life in years
|
|
5
|
|
|
5
|
|
|
5
|
|
|||
Expected volatility
|
|
32.9
|
%
|
|
34.2
|
%
|
|
35.7
|
%
|
|||
Expected dividend yield
|
|
1.6
|
%
|
|
0.9
|
%
|
|
0.7
|
%
|
|
|
Number of
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Non-vested at December 31, 2015
|
|
64,856
|
|
|
$
|
15.81
|
|
Granted
|
|
28,142
|
|
|
51.53
|
|
|
Vested
|
|
(81,134
|
)
|
|
28.19
|
|
|
Forfeited
|
|
(11,864
|
)
|
|
15.81
|
|
|
Non-vested at December 31, 2016
|
|
—
|
|
|
$
|
—
|
|
|
|
Number of
Units
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Non-vested at December 31, 2015
|
|
498,872
|
|
|
$
|
57.61
|
|
Granted
|
|
204,642
|
|
|
48.64
|
|
|
Vested
|
|
(88,877
|
)
|
|
48.28
|
|
|
Forfeited
|
|
(17,078
|
)
|
|
67.47
|
|
|
Non-vested at December 31, 2016
|
|
597,559
|
|
|
$
|
55.64
|
|
|
|
Liability Classified Restricted Stock Awards
|
|||
|
|
Year Ended December 31, 2016
|
|||
Weighted average vesting period in years
|
|
1.2
|
|
||
Risk-free interest rate
|
|
0.9
|
%
|
||
Expected volatility
|
|
28.2
|
%
|
||
Expected dividend yield
|
|
1.4
|
%
|
|
|
Number of
Units
|
|
Weighted Average Fair Value
|
|||
Non-vested at August 31, 2016
|
|
340,413
|
|
|
$
|
51.82
|
|
Vested
|
|
(54,266
|
)
|
|
52.88
|
|
|
Non-vested at December 31, 2016
|
|
286,147
|
|
|
$
|
60.77
|
|
|
|
Asset Derivatives
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of December 31,
|
||||||
|
|
2016
|
|
2015
|
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accounts receivable, net
|
|
$
|
7,727
|
|
|
$
|
3,465
|
|
Commodity forward contracts
|
|
Deferred charges and
other assets, net
|
|
7,259
|
|
|
2,088
|
|
||
Total asset derivatives
|
|
$
|
14,986
|
|
|
$
|
5,553
|
|
||
|
|
|
|
|
|
|
||||
|
|
Liability Derivatives
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of December 31,
|
||||||
|
|
2016
|
|
2015
|
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accrued liabilities
|
|
$
|
1,487
|
|
|
$
|
9,325
|
|
Commodity forward contracts
|
|
Other liabilities
|
|
5,734
|
|
|
12,437
|
|
||
Total liability derivatives
|
|
$
|
7,221
|
|
|
$
|
21,762
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss)
Recognized in Income on Derivative
|
|
Year Ended December 31,
|
||||||||||
2016
|
|
2015
|
|
2014
|
||||||||||
Commodity forward contracts
|
|
Cost of sales
|
|
$
|
19,696
|
|
|
$
|
(11,395
|
)
|
|
$
|
(9,678
|
)
|
|
|
2016
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets—Commodity forward contracts
|
|
$
|
878
|
|
|
$
|
14,108
|
|
|
$
|
14,986
|
|
Risk management liabilities—Commodity forward contracts
|
|
(6,854
|
)
|
|
(367
|
)
|
|
(7,221
|
)
|
|||
|
|
|
|
|
|
|
||||||
|
|
2015
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets—Commodity forward contracts
|
|
$
|
5,553
|
|
|
$
|
—
|
|
|
$
|
5,553
|
|
Risk management liabilities—Commodity forward contracts
|
|
(11,648
|
)
|
|
(10,114
|
)
|
|
(21,762
|
)
|
|||
Marketable securities
|
|
|
|
|
|
|
||||||
Available-for-sale securities
|
|
48,081
|
|
|
520,144
|
|
|
568,225
|
|
|
|
2016
|
|
2015
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
Revolving credit facility
|
|
$
|
325,000
|
|
|
$
|
325,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
4.625% Westlake Senior Notes 2021
|
|
651,630
|
|
|
650,847
|
|
|
—
|
|
|
—
|
|
||||
4.625% Subsidiary Senior Notes 2021
|
|
66,069
|
|
|
65,775
|
|
|
—
|
|
|
—
|
|
||||
3.60% senior notes due 2022
|
|
248,109
|
|
|
251,725
|
|
|
247,768
|
|
|
244,828
|
|
||||
4.875% Westlake Senior 2023 Notes
|
|
447,224
|
|
|
451,301
|
|
|
—
|
|
|
—
|
|
||||
4.875% Subsidiary 2023 Senior Notes
|
|
16,747
|
|
|
16,501
|
|
|
—
|
|
|
—
|
|
||||
3.60% 2026 Senior Notes
|
|
739,243
|
|
|
722,055
|
|
|
—
|
|
|
—
|
|
||||
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
||||
6 ½% senior notes due 2029
|
|
99,084
|
|
|
112,433
|
|
|
99,011
|
|
|
117,153
|
|
||||
6 ¾% senior notes due 2032
|
|
248,117
|
|
|
258,818
|
|
|
247,998
|
|
|
268,490
|
|
||||
6 ½% 2035 GO Zone Senior Notes
|
|
88,161
|
|
|
100,323
|
|
|
88,116
|
|
|
106,491
|
|
||||
6 ½% 2035 IKE Zone Senior Notes
|
|
64,398
|
|
|
73,270
|
|
|
64,366
|
|
|
76,741
|
|
||||
5.0% 2046 Senior Notes
|
|
673,983
|
|
|
691,712
|
|
|
—
|
|
|
—
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Current
|
|
|
|
|
|
|
||||||
Federal
|
|
$
|
8,156
|
|
|
$
|
225,617
|
|
|
$
|
300,610
|
|
State
|
|
8,967
|
|
|
23,966
|
|
|
37,351
|
|
|||
Foreign
|
|
20,720
|
|
|
9,029
|
|
|
1,974
|
|
|||
|
|
37,843
|
|
|
258,612
|
|
|
339,935
|
|
|||
Deferred
|
|
|
|
|
|
|
||||||
Federal
|
|
136,206
|
|
|
29,820
|
|
|
40,950
|
|
|||
State
|
|
(33,681
|
)
|
|
2,807
|
|
|
22,714
|
|
|||
Foreign
|
|
(1,848
|
)
|
|
7,157
|
|
|
(4,697
|
)
|
|||
|
|
100,677
|
|
|
39,784
|
|
|
58,967
|
|
|||
Total provision
|
|
$
|
138,520
|
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Provision for federal income tax, at statutory rate
|
|
$
|
195,432
|
|
|
$
|
337,204
|
|
|
$
|
379,371
|
|
State income tax provision, net of federal income tax effect
|
|
1,408
|
|
|
17,403
|
|
|
40,012
|
|
|||
Foreign income tax rate differential
|
|
(7,594
|
)
|
|
(13,002
|
)
|
|
3,640
|
|
|||
Manufacturing deduction
|
|
(2,371
|
)
|
|
(24,185
|
)
|
|
(24,465
|
)
|
|||
Depletion
|
|
(2,298
|
)
|
|
—
|
|
|
—
|
|
|||
Contingent tax liability
|
|
2,172
|
|
|
—
|
|
|
(1,626
|
)
|
|||
Noncontrolling interests
|
|
(6,940
|
)
|
|
(6,662
|
)
|
|
(2,255
|
)
|
|||
Tax on previously held shares of Axiall Corporation and certain
other acquisition related items
|
|
(12,924
|
)
|
|
—
|
|
|
—
|
|
|||
Changes in state apportionment and other state adjustments
|
|
(16,929
|
)
|
|
—
|
|
|
—
|
|
|||
Research and development expenditures and adjustments related to prior
years' tax returns
|
|
(8,344
|
)
|
|
|
|
|
|
|
|||
Other, net
|
|
(3,092
|
)
|
|
(12,362
|
)
|
|
4,225
|
|
|||
|
|
$
|
138,520
|
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
|
2016
|
|
2015
|
||||
Net operating loss carryforward
|
|
$
|
69,790
|
|
|
$
|
17,679
|
|
Credit carryforward
|
|
23,932
|
|
|
746
|
|
||
Accruals
|
|
66,694
|
|
|
57,811
|
|
||
Pension
|
|
113,644
|
|
|
4,393
|
|
||
Allowance for doubtful accounts
|
|
12,039
|
|
|
4,617
|
|
||
Inventories
|
|
13,257
|
|
|
8,663
|
|
||
Other
|
|
36,624
|
|
|
7,747
|
|
||
Deferred taxes assets—total
|
|
335,980
|
|
|
101,656
|
|
||
Property, plant and equipment
|
|
(1,374,095
|
)
|
|
(408,374
|
)
|
||
Intangibles
|
|
(220,489
|
)
|
|
(15,007
|
)
|
||
Turnaround costs
|
|
(701
|
)
|
|
(1,467
|
)
|
||
Basis difference—consolidated partnerships
|
|
(308,361
|
)
|
|
(200,627
|
)
|
||
Other
|
|
(17,377
|
)
|
|
—
|
|
||
Deferred tax liabilities—total
|
|
(1,921,023
|
)
|
|
(625,475
|
)
|
||
Valuation allowance
|
|
(53,006
|
)
|
|
(16,345
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,638,049
|
)
|
|
$
|
(540,164
|
)
|
|
|
|
|
|
||||
Balance sheet classifications
|
|
|
|
|
||||
Current deferred tax asset
|
|
$
|
—
|
|
|
$
|
35,439
|
|
Noncurrent deferred tax asset
|
|
12,526
|
|
|
—
|
|
||
Noncurrent deferred tax liability
|
|
(1,650,575
|
)
|
|
(575,603
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,638,049
|
)
|
|
$
|
(540,164
|
)
|
Beginning balance at January 1, 2016
|
|
$
|
—
|
|
Amounts attributable to Axiall pre-acquisition
|
|
5,030
|
|
|
Additions during the year ended December 31, 2016
|
|
3,398
|
|
|
Reductions due to statutes of limitations expiring
|
|
(1,184
|
)
|
|
Effects of changes in foreign exchange rates
|
|
$
|
(56
|
)
|
Ending balance at December 31, 2016
|
|
$
|
7,188
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
398,859
|
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
Less:
|
|
|
|
|
|
|
||||||
Net income attributable to participating securities
|
|
(1,784
|
)
|
|
(2,825
|
)
|
|
(1,502
|
)
|
|||
Net income attributable to common shareholders
|
|
$
|
397,075
|
|
|
$
|
643,185
|
|
|
$
|
677,021
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Weighted average common shares—basic
|
|
129,367,712
|
|
|
131,823,707
|
|
|
133,111,230
|
|
|||
Plus incremental shares from:
|
|
|
|
|
|
|
||||||
Assumed exercise of options
|
|
607,110
|
|
|
478,105
|
|
|
532,184
|
|
|||
Weighted average common shares—diluted
|
|
129,974,822
|
|
|
132,301,812
|
|
|
133,643,414
|
|
|||
|
|
|
|
|
|
|
||||||
Earnings per common share attributable to
Westlake Chemical Corporation:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
Diluted
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Interest income
|
|
$
|
8,421
|
|
|
$
|
6,034
|
|
|
$
|
3,468
|
|
Dividend income
|
|
4,821
|
|
|
3,559
|
|
|
532
|
|
|||
Acquisition-related financing costs
|
|
(12,453
|
)
|
|
—
|
|
|
—
|
|
|||
Foreign exchange currency gains (losses), net
(1)
|
|
122
|
|
|
1,828
|
|
|
(7,382
|
)
|
|||
Income from equity method investments
|
|
3,613
|
|
|
6,242
|
|
|
5,883
|
|
|||
Impairment of equity method investments
|
|
—
|
|
|
(4,925
|
)
|
|
(6,747
|
)
|
|||
Gain realized on previously held shares of Axiall common stock
|
|
49,080
|
|
|
—
|
|
|
—
|
|
|||
Gain on acquisition and related expenses, net
|
|
—
|
|
|
20,430
|
|
|
—
|
|
|||
Gain from sales of securities, net
|
|
4,640
|
|
|
3,798
|
|
|
1,212
|
|
|||
Other
|
|
(1,846
|
)
|
|
1,304
|
|
|
313
|
|
|||
Other income (expense), net
|
|
$
|
56,398
|
|
|
$
|
38,270
|
|
|
$
|
(2,721
|
)
|
(1)
|
Aggregate foreign exchange currency gains and losses included in the consolidated statements of operations for the years ended
December 31, 2016
,
2015
and
2014
.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Cash paid for:
|
|
|
|
|
|
|
||||||
Interest paid, net of interest capitalized
|
|
$
|
45,534
|
|
|
$
|
31,946
|
|
|
$
|
35,336
|
|
Income taxes paid
|
|
3,066
|
|
|
314,186
|
|
|
314,745
|
|
Total proceeds from the initial public offering
|
|
$
|
310,500
|
|
Less: Offering Costs
|
|
(24,412
|
)
|
|
Net proceeds from the initial public offering
|
|
286,088
|
|
|
Less: Cash retained by OpCo
|
|
(55,419
|
)
|
|
Net proceeds distributed to the Company from the initial public offering
|
|
$
|
230,669
|
|
•
|
In May 2013, an amendment to an existing consent order agreed to by the West Virginia Department of Environmental Protection and a predecessor of Axiall required that it, among other things, pay a penalty in the amount of
$449
and continue certain corrective action associated with discharges of hexachlorocyclohexane (commonly referred to as BHC) from the Natrium, West Virginia facility's effluent discharge outfalls. The penalty was paid and corrective actions required under the amendment to the consent order are on-going.
|
•
|
In May 2013 and September 2013, the Environmental Protection Agency (the "EPA") conducted inspections at the Company's Plaquemine, Louisiana facility pursuant to requirements of the federal Clean Air Act Section 112(r) Risk Management Program and Title V. As a result of the inspections, the EPA identified areas of concern and the Company has subsequently engaged in negotiations, which are anticipated to result in sanctions of
$167
.
|
•
|
The LDEQ has issued notices of violations ("NOVs") regarding the Company's olefins facilities in Lake Charles, Louisiana for various air and water compliance issues. The Company is working with the LDEQ to settle these claims, and a global settlement of all claims is being discussed. The Company has reached a verbal agreement with the LDEQ to settle certain of the NOVs in
two
separate settlements for a combined
$192
in civil penalties.
|
•
|
During September 2010, the Company's vinyls facilities in north Lake Charles and Plaquemine each received a Consolidated Compliance Order and Notice of Potential Penalty, alleging violations of various requirements of those facilities' air permits, based largely on self-reported permit deviations related to record-keeping violations. The Company has been negotiating a possible global settlement of these and several other matters with the LDEQ. The Company believes the resolution of these matters may require the payment of a monetary sanction in excess of
$100
.
|
•
|
In April 2015, Axiall received a communication from the EPA related to, among other things, the EPA's investigation of the 2012 and 2013 fires that occurred at its VCM plant in Lake Charles. In late 2015, Axiall settled this matter with the EPA, with such settlement including on-going supplemental environmental projects and a payment of
$900
.
|
•
|
For several years, the EPA has been conducting an enforcement initiative against petroleum refineries and petrochemical plants with respect to emissions from flares. On April 21, 2014, the Company received a Clean Air Act Section 114 Information Request from the EPA which sought information regarding flares at the Calvert City, Kentucky facility and certain Lake Charles facilities. The EPA has informed the Company that the information provided leads the EPA to believe that some of the flares are out of compliance with applicable standards. The EPA has indicated that it is seeking a consent decree that would obligate the Company to take corrective actions relating to the alleged noncompliance. The Company believes the resolution of these matters may require the payment of a monetary sanction in excess of
$100
.
|
|
|
Operating
Leases
|
|
Capital
Leases
|
||||
2017
|
|
$
|
86,910
|
|
|
$
|
3,713
|
|
2018
|
|
78,941
|
|
|
3,627
|
|
||
2019
|
|
60,885
|
|
|
3,367
|
|
||
2020
|
|
48,395
|
|
|
3,367
|
|
||
2021
|
|
39,626
|
|
|
2,610
|
|
||
Thereafter
|
|
603,621
|
|
|
13,943
|
|
||
Total minimum lease payments
|
|
$
|
918,378
|
|
|
$
|
30,627
|
|
Less: Imputed interest costs
|
|
|
|
(10,681
|
)
|
|||
Present value of net minimum lease payments
|
|
|
|
$
|
19,946
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,462,407
|
|
|
$
|
1,650,964
|
|
|
$
|
1,922,535
|
|
Styrene, feedstock and other
|
|
431,227
|
|
|
609,149
|
|
|
801,155
|
|
|||
Total olefins
|
|
1,893,634
|
|
|
2,260,113
|
|
|
2,723,690
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
2,492,562
|
|
|
1,718,359
|
|
|
1,203,332
|
|
|||
Building products
|
|
689,260
|
|
|
484,864
|
|
|
488,328
|
|
|||
Total vinyls
|
|
3,181,822
|
|
|
2,203,223
|
|
|
1,691,660
|
|
|||
|
|
$
|
5,075,456
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
|
|
|
|
|
|
||||||
Intersegment sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
165,266
|
|
|
$
|
106,861
|
|
|
$
|
146,539
|
|
Vinyls
|
|
25,809
|
|
|
1,493
|
|
|
1,385
|
|
|||
|
|
$
|
191,075
|
|
|
$
|
108,354
|
|
|
$
|
147,924
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
557,806
|
|
|
$
|
747,436
|
|
|
$
|
1,013,825
|
|
Vinyls
|
|
174,141
|
|
|
254,452
|
|
|
142,740
|
|
|||
Corporate and other
|
|
(150,493
|
)
|
|
(42,061
|
)
|
|
(32,574
|
)
|
|||
|
|
$
|
581,454
|
|
|
$
|
959,827
|
|
|
$
|
1,123,991
|
|
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
136,500
|
|
|
$
|
110,684
|
|
|
$
|
106,244
|
|
Vinyls
|
|
237,588
|
|
|
134,546
|
|
|
101,666
|
|
|||
Corporate and other
|
|
3,578
|
|
|
527
|
|
|
576
|
|
|||
|
|
$
|
377,666
|
|
|
$
|
245,757
|
|
|
$
|
208,486
|
|
|
|
|
|
|
|
|
||||||
Other income (expense), net
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
5,156
|
|
|
$
|
4,656
|
|
|
$
|
6,102
|
|
Vinyls
|
|
3,138
|
|
|
8,540
|
|
|
2,680
|
|
|||
Corporate and other
|
|
48,104
|
|
|
25,074
|
|
|
(11,503
|
)
|
|||
|
|
$
|
56,398
|
|
|
$
|
38,270
|
|
|
$
|
(2,721
|
)
|
|
|
|
|
|
|
|
||||||
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
175,394
|
|
|
$
|
242,516
|
|
|
$
|
354,159
|
|
Vinyls
|
|
24,695
|
|
|
64,456
|
|
|
52,249
|
|
|||
Corporate and other
|
|
(61,569
|
)
|
|
(8,576
|
)
|
|
(7,506
|
)
|
|||
|
|
$
|
138,520
|
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
|
|
|
|
|
|
||||||
Capital expenditures
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
323,590
|
|
|
$
|
304,873
|
|
|
$
|
188,729
|
|
Vinyls
|
|
302,208
|
|
|
176,582
|
|
|
237,992
|
|
|||
Corporate and other
|
|
2,685
|
|
|
9,971
|
|
|
4,383
|
|
|||
|
|
$
|
628,483
|
|
|
$
|
491,426
|
|
|
$
|
431,104
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
2,092,617
|
|
|
$
|
1,869,888
|
|
Vinyls
|
|
8,287,204
|
|
|
2,638,833
|
|
||
Corporate and other
|
|
510,432
|
|
|
1,060,564
|
|
||
|
|
$
|
10,890,253
|
|
|
$
|
5,569,285
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Income from operations for reportable segments
|
|
$
|
581,454
|
|
|
$
|
959,827
|
|
|
$
|
1,123,991
|
|
Interest expense
|
|
(79,473
|
)
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|||
Other income (expense), net
|
|
56,398
|
|
|
38,270
|
|
|
(2,721
|
)
|
|||
Income before income taxes
|
|
$
|
558,379
|
|
|
$
|
963,441
|
|
|
$
|
1,083,918
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Sales to external customers
(1)
|
|
|
|
|
|
|
||||||
United States
|
|
$
|
3,525,492
|
|
|
$
|
3,133,395
|
|
|
$
|
3,596,091
|
|
Foreign
|
|
|
|
|
|
|
||||||
Germany
|
|
401,950
|
|
|
394,459
|
|
|
198,921
|
|
|||
Canada
|
|
317,083
|
|
|
195,790
|
|
|
217,567
|
|
|||
Switzerland
|
|
101,320
|
|
|
106,750
|
|
|
89,214
|
|
|||
China
|
|
87,118
|
|
|
46,451
|
|
|
6,515
|
|
|||
Italy
|
|
84,359
|
|
|
90,237
|
|
|
36,823
|
|
|||
Belgium
|
|
50,662
|
|
|
41,542
|
|
|
24,082
|
|
|||
France
|
|
50,371
|
|
|
58,727
|
|
|
27,521
|
|
|||
Other
|
|
457,101
|
|
|
395,985
|
|
|
218,616
|
|
|||
|
|
$
|
5,075,456
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
|
December 31, 2016
|
|
December 31, 2015
|
||||
Long-lived assets
|
|
|
|
|
||||
United States
|
|
$
|
5,782,796
|
|
|
$
|
2,588,366
|
|
Foreign
|
|
|
|
|
||||
Germany
|
|
401,572
|
|
|
379,262
|
|
||
Other
|
|
235,694
|
|
|
36,439
|
|
||
|
|
$
|
6,420,062
|
|
|
$
|
3,004,067
|
|
(1)
|
Revenues are attributed to countries based on location of customer.
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
146,990
|
|
|
$
|
53,006
|
|
|
$
|
259,457
|
|
|
$
|
—
|
|
|
$
|
459,453
|
|
Accounts receivable, net
|
|
2,117,540
|
|
|
3,329,871
|
|
|
323,931
|
|
|
(4,832,599
|
)
|
|
938,743
|
|
|||||
Inventories
|
|
—
|
|
|
597,819
|
|
|
203,281
|
|
|
—
|
|
|
801,100
|
|
|||||
Prepaid expenses and other current assets
|
|
30,748
|
|
|
41,755
|
|
|
12,494
|
|
|
(36,504
|
)
|
|
48,493
|
|
|||||
Restricted cash
|
|
—
|
|
|
—
|
|
|
160,527
|
|
|
—
|
|
|
160,527
|
|
|||||
Total current assets
|
|
2,295,278
|
|
|
4,022,451
|
|
|
959,690
|
|
|
(4,869,103
|
)
|
|
2,408,316
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
4,475,943
|
|
|
1,944,119
|
|
|
—
|
|
|
6,420,062
|
|
|||||
Other assets, net
|
|
9,170,042
|
|
|
2,264,597
|
|
|
1,484,871
|
|
|
(10,857,635
|
)
|
|
2,061,875
|
|
|||||
Total assets
|
|
$
|
11,465,320
|
|
|
$
|
10,762,991
|
|
|
$
|
4,388,680
|
|
|
$
|
(15,726,738
|
)
|
|
$
|
10,890,253
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts and notes payable
|
|
$
|
4,330,375
|
|
|
$
|
748,364
|
|
|
$
|
225,300
|
|
|
$
|
(4,807,780
|
)
|
|
$
|
496,259
|
|
Accrued liabilities
|
|
26,367
|
|
|
389,216
|
|
|
183,223
|
|
|
(61,323
|
)
|
|
537,483
|
|
|||||
Term loan
|
|
—
|
|
|
—
|
|
|
149,341
|
|
|
—
|
|
|
149,341
|
|
|||||
Total current liabilities
|
|
4,356,742
|
|
|
1,137,580
|
|
|
557,864
|
|
|
(4,869,103
|
)
|
|
1,183,083
|
|
|||||
Long-term debt
|
|
3,584,949
|
|
|
4,090,775
|
|
|
—
|
|
|
(3,997,070
|
)
|
|
3,678,654
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
1,581,260
|
|
|
91,809
|
|
|
(22,494
|
)
|
|
1,650,575
|
|
|||||
Pension and other liabilities
|
|
—
|
|
|
360,622
|
|
|
125,274
|
|
|
—
|
|
|
485,896
|
|
|||||
Total liabilities
|
|
7,941,691
|
|
|
7,170,237
|
|
|
774,947
|
|
|
(8,888,667
|
)
|
|
6,998,208
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,523,629
|
|
|
3,592,754
|
|
|
3,245,317
|
|
|
(6,838,071
|
)
|
|
3,523,629
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
368,416
|
|
|
—
|
|
|
368,416
|
|
|||||
Total equity
|
|
3,523,629
|
|
|
3,592,754
|
|
|
3,613,733
|
|
|
(6,838,071
|
)
|
|
3,892,045
|
|
|||||
Total liabilities and equity
|
|
$
|
11,465,320
|
|
|
$
|
10,762,991
|
|
|
$
|
4,388,680
|
|
|
$
|
(15,726,738
|
)
|
|
$
|
10,890,253
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
303,131
|
|
|
$
|
6,818
|
|
|
$
|
352,576
|
|
|
$
|
—
|
|
|
$
|
662,525
|
|
Marketable securities
|
|
520,144
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
520,144
|
|
|||||
Accounts receivable, net
|
|
10,943
|
|
|
2,474,963
|
|
|
190,384
|
|
|
(2,167,758
|
)
|
|
508,532
|
|
|||||
Inventories
|
|
—
|
|
|
287,114
|
|
|
146,946
|
|
|
—
|
|
|
434,060
|
|
|||||
Prepaid expenses and other current assets
|
|
2,201
|
|
|
10,186
|
|
|
4,981
|
|
|
(2,879
|
)
|
|
14,489
|
|
|||||
Deferred income taxes
|
|
702
|
|
|
28,325
|
|
|
6,412
|
|
|
—
|
|
|
35,439
|
|
|||||
Total current assets
|
|
837,121
|
|
|
2,807,406
|
|
|
701,299
|
|
|
(2,170,637
|
)
|
|
2,175,189
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
1,476,642
|
|
|
1,527,425
|
|
|
—
|
|
|
3,004,067
|
|
|||||
Other assets, net
|
|
5,003,096
|
|
|
914,823
|
|
|
1,442,436
|
|
|
(6,970,326
|
)
|
|
390,029
|
|
|||||
Total assets
|
|
$
|
5,840,217
|
|
|
$
|
5,198,871
|
|
|
$
|
3,671,160
|
|
|
$
|
(9,140,963
|
)
|
|
$
|
5,569,285
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
1,817,963
|
|
|
$
|
374,468
|
|
|
$
|
185,931
|
|
|
$
|
(2,143,033
|
)
|
|
$
|
235,329
|
|
Accrued liabilities
|
|
9,117
|
|
|
163,167
|
|
|
142,633
|
|
|
(27,604
|
)
|
|
287,313
|
|
|||||
Total current liabilities
|
|
1,827,080
|
|
|
537,635
|
|
|
328,564
|
|
|
(2,170,637
|
)
|
|
522,642
|
|
|||||
Long-term debt
|
|
747,259
|
|
|
744,405
|
|
|
—
|
|
|
(733,516
|
)
|
|
758,148
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
513,692
|
|
|
68,478
|
|
|
(6,567
|
)
|
|
575,603
|
|
|||||
Pension and other liabilities
|
|
—
|
|
|
49,202
|
|
|
101,759
|
|
|
—
|
|
|
150,961
|
|
|||||
Total liabilities
|
|
2,574,339
|
|
|
1,844,934
|
|
|
498,801
|
|
|
(2,910,720
|
)
|
|
2,007,354
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,265,878
|
|
|
3,353,937
|
|
|
2,876,306
|
|
|
(6,230,243
|
)
|
|
3,265,878
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
296,053
|
|
|
—
|
|
|
296,053
|
|
|||||
Total equity
|
|
3,265,878
|
|
|
3,353,937
|
|
|
3,172,359
|
|
|
(6,230,243
|
)
|
|
3,561,931
|
|
|||||
Total liabilities and equity
|
|
$
|
5,840,217
|
|
|
$
|
5,198,871
|
|
|
$
|
3,671,160
|
|
|
$
|
(9,140,963
|
)
|
|
$
|
5,569,285
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
4,009,891
|
|
|
$
|
2,444,878
|
|
|
$
|
(1,379,313
|
)
|
|
$
|
5,075,456
|
|
Cost of sales
|
|
—
|
|
|
3,532,638
|
|
|
1,919,598
|
|
|
(1,357,342
|
)
|
|
4,094,894
|
|
|||||
Gross profit
|
|
—
|
|
|
477,253
|
|
|
525,280
|
|
|
(21,971
|
)
|
|
980,562
|
|
|||||
Selling, general and administrative expenses
|
|
3,488
|
|
|
204,353
|
|
|
109,566
|
|
|
(21,971
|
)
|
|
295,436
|
|
|||||
Transaction and integration-related costs
|
|
—
|
|
|
103,226
|
|
|
446
|
|
|
—
|
|
|
103,672
|
|
|||||
(Loss) income from operations
|
|
(3,488
|
)
|
|
169,674
|
|
|
415,268
|
|
|
—
|
|
|
581,454
|
|
|||||
Interest expense
|
|
(82,908
|
)
|
|
(75,907
|
)
|
|
(2,578
|
)
|
|
81,920
|
|
|
(79,473
|
)
|
|||||
Other income (expense), net
|
|
77,151
|
|
|
(14,247
|
)
|
|
75,414
|
|
|
(81,920
|
)
|
|
56,398
|
|
|||||
(Loss) income before income taxes
|
|
(9,245
|
)
|
|
79,520
|
|
|
488,104
|
|
|
—
|
|
|
558,379
|
|
|||||
(Benefit from) provision for income taxes
|
|
(8,047
|
)
|
|
115,457
|
|
|
31,110
|
|
|
—
|
|
|
138,520
|
|
|||||
Equity in net income of subsidiaries
|
|
400,057
|
|
|
—
|
|
|
—
|
|
|
(400,057
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
398,859
|
|
|
(35,937
|
)
|
|
456,994
|
|
|
(400,057
|
)
|
|
419,859
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
21,000
|
|
|
—
|
|
|
21,000
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
398,859
|
|
|
$
|
(35,937
|
)
|
|
$
|
435,994
|
|
|
$
|
(400,057
|
)
|
|
$
|
398,859
|
|
Comprehensive income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
406,845
|
|
|
$
|
11,695
|
|
|
$
|
395,682
|
|
|
$
|
(407,377
|
)
|
|
$
|
406,845
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
3,557,806
|
|
|
$
|
2,286,407
|
|
|
$
|
(1,380,877
|
)
|
|
$
|
4,463,336
|
|
Cost of sales
|
|
—
|
|
|
2,842,466
|
|
|
1,796,734
|
|
|
(1,361,055
|
)
|
|
3,278,145
|
|
|||||
Gross profit
|
|
—
|
|
|
715,340
|
|
|
489,673
|
|
|
(19,822
|
)
|
|
1,185,191
|
|
|||||
Selling, general and administrative expenses
|
|
2,478
|
|
|
150,968
|
|
|
91,740
|
|
|
(19,822
|
)
|
|
225,364
|
|
|||||
(Loss) income from operations
|
|
(2,478
|
)
|
|
564,372
|
|
|
397,933
|
|
|
—
|
|
|
959,827
|
|
|||||
Interest expense
|
|
(42,197
|
)
|
|
(34,667
|
)
|
|
—
|
|
|
42,208
|
|
|
(34,656
|
)
|
|||||
Other income (expense), net
|
|
19,614
|
|
|
5,576
|
|
|
55,288
|
|
|
(42,208
|
)
|
|
38,270
|
|
|||||
(Loss) income before income taxes
|
|
(25,061
|
)
|
|
535,281
|
|
|
453,221
|
|
|
—
|
|
|
963,441
|
|
|||||
Provision for (benefit from) income taxes
|
|
(7,237
|
)
|
|
275,687
|
|
|
29,946
|
|
|
—
|
|
|
298,396
|
|
|||||
Equity in net income of subsidiaries
|
|
663,834
|
|
|
—
|
|
|
—
|
|
|
(663,834
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
646,010
|
|
|
259,594
|
|
|
423,275
|
|
|
(663,834
|
)
|
|
665,045
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
19,035
|
|
|
—
|
|
|
19,035
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
259,594
|
|
|
$
|
404,240
|
|
|
$
|
(663,834
|
)
|
|
$
|
646,010
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
596,151
|
|
|
$
|
261,392
|
|
|
$
|
334,447
|
|
|
$
|
(595,839
|
)
|
|
$
|
596,151
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
3,617,627
|
|
|
$
|
2,492,099
|
|
|
$
|
(1,694,376
|
)
|
|
$
|
4,415,350
|
|
Cost of sales
|
|
—
|
|
|
3,056,659
|
|
|
1,714,415
|
|
|
(1,673,074
|
)
|
|
3,098,000
|
|
|||||
Gross profit
|
|
—
|
|
|
560,968
|
|
|
777,684
|
|
|
(21,302
|
)
|
|
1,317,350
|
|
|||||
Selling, general and administrative expenses
|
|
2,082
|
|
|
121,182
|
|
|
81,783
|
|
|
(21,302
|
)
|
|
183,745
|
|
|||||
Transaction and integration-related costs
|
|
—
|
|
|
7,411
|
|
|
2,203
|
|
|
—
|
|
|
9,614
|
|
|||||
(Loss) income from operations
|
|
(2,082
|
)
|
|
432,375
|
|
|
693,698
|
|
|
—
|
|
|
1,123,991
|
|
|||||
Interest expense
|
|
(39,763
|
)
|
|
(26,218
|
)
|
|
—
|
|
|
28,629
|
|
|
(37,352
|
)
|
|||||
Other income (expense), net
|
|
21,001
|
|
|
(4,278
|
)
|
|
9,185
|
|
|
(28,629
|
)
|
|
(2,721
|
)
|
|||||
(Loss) income before income taxes
|
|
(20,844
|
)
|
|
401,879
|
|
|
702,883
|
|
|
—
|
|
|
1,083,918
|
|
|||||
(Benefit from) provision for income taxes
|
|
248
|
|
|
192,659
|
|
|
205,995
|
|
|
—
|
|
|
398,902
|
|
|||||
Equity in net income of subsidiaries
|
|
699,615
|
|
|
—
|
|
|
—
|
|
|
(699,615
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
678,523
|
|
|
209,220
|
|
|
496,888
|
|
|
(699,615
|
)
|
|
685,016
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
6,493
|
|
|
—
|
|
|
6,493
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
678,523
|
|
|
$
|
209,220
|
|
|
$
|
490,395
|
|
|
$
|
(699,615
|
)
|
|
$
|
678,523
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
601,706
|
|
|
$
|
203,428
|
|
|
$
|
419,313
|
|
|
$
|
(622,741
|
)
|
|
$
|
601,706
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
398,859
|
|
|
$
|
(35,937
|
)
|
|
$
|
456,994
|
|
|
$
|
(400,057
|
)
|
|
$
|
419,859
|
|
Adjustments to reconcile net income to net cash
(used for) provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
216,374
|
|
|
161,292
|
|
|
—
|
|
|
377,666
|
|
|||||
Deferred income taxes
|
|
1,214
|
|
|
103,315
|
|
|
(3,852
|
)
|
|
—
|
|
|
100,677
|
|
|||||
Net changes in working capital and other
|
|
(437,148
|
)
|
|
90,183
|
|
|
(117,442
|
)
|
|
400,057
|
|
|
(64,350
|
)
|
|||||
Net cash (used for) provided by operating activities
|
|
(37,075
|
)
|
|
373,935
|
|
|
496,992
|
|
|
—
|
|
|
833,852
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
(2,502,018
|
)
|
|
64,189
|
|
|
—
|
|
|
(2,437,829
|
)
|
|||||
Additions to cost method investments
|
|
—
|
|
|
(17,000
|
)
|
|
—
|
|
|
—
|
|
|
(17,000
|
)
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(274,564
|
)
|
|
(353,919
|
)
|
|
—
|
|
|
(628,483
|
)
|
|||||
Proceeds from disposition of assets
|
|
—
|
|
|
1,037
|
|
|
170
|
|
|
—
|
|
|
1,207
|
|
|||||
Proceeds from sales and maturities of securities
|
|
658,338
|
|
|
—
|
|
|
4,600
|
|
|
—
|
|
|
662,938
|
|
|||||
Purchase of securities
|
|
(138,422
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(138,422
|
)
|
|||||
Settlements of derivative instruments
|
|
—
|
|
|
(5,211
|
)
|
|
—
|
|
|
—
|
|
|
(5,211
|
)
|
|||||
Net cash provided by (used for) investing activities
|
|
519,916
|
|
|
(2,797,756
|
)
|
|
(284,960
|
)
|
|
—
|
|
|
(2,562,800
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
(2,199,148
|
)
|
|
2,207,119
|
|
|
(7,971
|
)
|
|
—
|
|
|
—
|
|
|||||
Capitalized debt issuance costs
|
|
(34,183
|
)
|
|
—
|
|
|
(1,590
|
)
|
|
—
|
|
|
(35,773
|
)
|
|||||
Dividends paid
|
|
(96,560
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(96,560
|
)
|
|||||
Distributions paid
|
|
—
|
|
|
262,890
|
|
|
(279,527
|
)
|
|
—
|
|
|
(16,637
|
)
|
|||||
Proceeds from debt issuance
|
|
1,428,512
|
|
|
—
|
|
|
|
|
|
—
|
|
|
1,428,512
|
|
|||||
Proceeds from exercise of stock options
|
|
2,179
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,179
|
|
|||||
Proceeds from issuance of notes payable
|
|
—
|
|
|
—
|
|
|
8,324
|
|
|
—
|
|
|
8,324
|
|
|||||
Proceeds from term loan and drawdown of revolver
|
|
450,000
|
|
|
—
|
|
|
150,000
|
|
|
—
|
|
|
600,000
|
|
|||||
Restricted cash associated with term loan
|
|
—
|
|
|
—
|
|
|
(154,000
|
)
|
|
—
|
|
|
(154,000
|
)
|
|||||
Repayment of debt
|
|
—
|
|
|
—
|
|
|
(13,046
|
)
|
|
—
|
|
|
(13,046
|
)
|
|||||
Repayment of revolver
|
|
(125,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(125,000
|
)
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Repurchase of common stock for treasury
|
|
$
|
(67,406
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(67,406
|
)
|
Windfall tax benefits from share-based payment arrangements
|
|
2,624
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,624
|
|
|||||
Net cash (used for) provided by financing activities
|
|
(638,982
|
)
|
|
2,470,009
|
|
|
(297,810
|
)
|
|
—
|
|
|
1,533,217
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
(7,341
|
)
|
|
—
|
|
|
(7,341
|
)
|
|||||
Net (decrease) increase in cash and cash equivalents
|
|
(156,141
|
)
|
|
46,188
|
|
|
(93,119
|
)
|
|
—
|
|
|
(203,072
|
)
|
|||||
Cash and cash equivalents at beginning of the year
|
|
303,131
|
|
|
6,818
|
|
|
352,576
|
|
|
—
|
|
|
662,525
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
146,990
|
|
|
$
|
53,006
|
|
|
$
|
259,457
|
|
|
$
|
—
|
|
|
$
|
459,453
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
646,010
|
|
|
$
|
259,594
|
|
|
$
|
423,275
|
|
|
$
|
(663,834
|
)
|
|
$
|
665,045
|
|
Adjustments to reconcile net income to net cash
(used for) provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
113,575
|
|
|
132,182
|
|
|
—
|
|
|
245,757
|
|
|||||
Deferred income taxes
|
|
(285
|
)
|
|
38,680
|
|
|
1,389
|
|
|
—
|
|
|
39,784
|
|
|||||
Net changes in working capital and other
|
|
(658,773
|
)
|
|
93,633
|
|
|
29,556
|
|
|
663,834
|
|
|
128,250
|
|
|||||
Net cash (used for) provided by operating activities
|
|
(13,048
|
)
|
|
505,482
|
|
|
586,402
|
|
|
—
|
|
|
1,078,836
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
15,782
|
|
|
—
|
|
|
15,782
|
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(215,405
|
)
|
|
(276,021
|
)
|
|
—
|
|
|
(491,426
|
)
|
|||||
Proceeds from disposition of assets
|
|
—
|
|
|
18
|
|
|
31
|
|
|
—
|
|
|
49
|
|
|||||
Proceeds from disposition of equity method investment
|
|
—
|
|
|
27,865
|
|
|
—
|
|
|
—
|
|
|
27,865
|
|
|||||
Proceeds from sales and maturities of securities
|
|
48,900
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
48,900
|
|
|||||
Purchase of securities
|
|
(556,211
|
)
|
|
(48,887
|
)
|
|
—
|
|
|
—
|
|
|
(605,098
|
)
|
|||||
Settlements of derivative instruments
|
|
—
|
|
|
(2,248
|
)
|
|
—
|
|
|
—
|
|
|
(2,248
|
)
|
|||||
Net cash (used for) provided by investing activities
|
|
(507,311
|
)
|
|
(238,657
|
)
|
|
(260,208
|
)
|
|
—
|
|
|
(1,006,176
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
418,844
|
|
|
(590,114
|
)
|
|
171,270
|
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(91,551
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
|||||
Distributions paid
|
|
—
|
|
|
327,060
|
|
|
(341,916
|
)
|
|
—
|
|
|
(14,856
|
)
|
|||||
Proceeds from exercise of stock options
|
|
1,063
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,063
|
|
|||||
Proceeds from issuance of notes payable
|
|
—
|
|
|
—
|
|
|
52,960
|
|
|
—
|
|
|
52,960
|
|
|||||
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
(73,615
|
)
|
|
—
|
|
|
(73,615
|
)
|
|||||
Repurchase of common stock for treasury
|
|
(162,459
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(162,459
|
)
|
|||||
Windfall tax benefits from share-based payment arrangements
|
|
1,646
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,646
|
|
|||||
Net cash provided by (used for) financing activities
|
|
$
|
167,543
|
|
|
$
|
(263,054
|
)
|
|
$
|
(191,301
|
)
|
|
$
|
—
|
|
|
$
|
(286,812
|
)
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(3,924
|
)
|
|
$
|
—
|
|
|
$
|
(3,924
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
(352,816
|
)
|
|
3,771
|
|
|
130,969
|
|
|
—
|
|
|
(218,076
|
)
|
|||||
Cash and cash equivalents at beginning of the year
|
|
655,947
|
|
|
3,047
|
|
|
221,607
|
|
|
—
|
|
|
880,601
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
303,131
|
|
|
$
|
6,818
|
|
|
$
|
352,576
|
|
|
$
|
—
|
|
|
$
|
662,525
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
678,523
|
|
|
$
|
209,220
|
|
|
$
|
496,888
|
|
|
$
|
(699,615
|
)
|
|
$
|
685,016
|
|
Adjustments to reconcile net income (loss) to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
101,779
|
|
|
106,707
|
|
|
—
|
|
|
208,486
|
|
|||||
Deferred income taxes
|
|
(288
|
)
|
|
47,692
|
|
|
11,563
|
|
|
—
|
|
|
58,967
|
|
|||||
Net changes in working capital and other
|
|
(704,370
|
)
|
|
(560,996
|
)
|
|
645,658
|
|
|
699,615
|
|
|
79,907
|
|
|||||
Net cash (used for) provided by operating activities
|
|
(26,135
|
)
|
|
(202,305
|
)
|
|
1,260,816
|
|
|
—
|
|
|
1,032,376
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business
|
|
—
|
|
|
—
|
|
|
(611,087
|
)
|
|
—
|
|
|
(611,087
|
)
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(209,111
|
)
|
|
(221,993
|
)
|
|
—
|
|
|
(431,104
|
)
|
|||||
Proceeds from disposition of assets
|
|
—
|
|
|
180
|
|
|
1
|
|
|
—
|
|
|
181
|
|
|||||
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
—
|
|
|
45,923
|
|
|
—
|
|
|
45,923
|
|
|||||
Proceeds from sales and maturities of securities
|
|
342,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
342,045
|
|
|||||
Purchase of securities
|
|
(117,332
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(117,332
|
)
|
|||||
Settlements of derivative instruments
|
|
—
|
|
|
(1,698
|
)
|
|
(133
|
)
|
|
—
|
|
|
(1,831
|
)
|
|||||
Net cash used for investing activities
|
|
224,713
|
|
|
(210,629
|
)
|
|
(787,289
|
)
|
|
—
|
|
|
(773,205
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
155,665
|
|
|
(244,122
|
)
|
|
88,457
|
|
|
—
|
|
|
—
|
|
|||||
Net distributions prior to Westlake Partners initial public offering
|
|
—
|
|
|
448,101
|
|
|
(448,101
|
)
|
|
—
|
|
|
—
|
|
|||||
Capitalized debt issuance costs
|
|
(1,186
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,186
|
)
|
|||||
Dividends paid
|
|
(77,656
|
)
|
|
151,729
|
|
|
(151,729
|
)
|
|
—
|
|
|
(77,656
|
)
|
|||||
Distributions paid
|
|
—
|
|
|
54,060
|
|
|
(56,264
|
)
|
|
—
|
|
|
(2,204
|
)
|
|||||
Net proceeds from issuance of Westlake Partners common units
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
—
|
|
|
286,088
|
|
|||||
Proceeds from exercise of stock options
|
|
5,524
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,524
|
|
|||||
Repurchase of common stock for treasury
|
|
(52,630
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,630
|
)
|
|||||
Windfall tax benefits from share-based payment arrangements
|
|
6,704
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,704
|
|
|||||
Net cash provided (used for) by financing activities
|
|
$
|
36,421
|
|
|
$
|
409,768
|
|
|
$
|
(281,549
|
)
|
|
$
|
—
|
|
|
$
|
164,640
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(4,511
|
)
|
|
$
|
—
|
|
|
$
|
(4,511
|
)
|
Net (decrease) increase in cash and cash equivalents
|
|
234,999
|
|
|
(3,166
|
)
|
|
187,467
|
|
|
—
|
|
|
419,300
|
|
|||||
Cash and cash equivalents at beginning of the year
|
|
420,948
|
|
|
6,213
|
|
|
34,140
|
|
|
—
|
|
|
461,301
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
655,947
|
|
|
$
|
3,047
|
|
|
$
|
221,607
|
|
|
$
|
—
|
|
|
$
|
880,601
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2016 |
|
June 30,
2016 |
|
September 30,
2016 |
|
December 31,
2016 |
||||||||
Net sales
|
|
$
|
975,187
|
|
|
$
|
1,086,061
|
|
|
$
|
1,279,028
|
|
|
$
|
1,735,180
|
|
Gross profit
|
|
255,585
|
|
|
241,366
|
|
|
202,133
|
|
|
281,478
|
|
||||
Income from operations
|
|
202,276
|
|
|
179,938
|
|
|
46,563
|
|
|
152,677
|
|
||||
Net income
|
|
128,936
|
|
|
115,620
|
|
|
70,014
|
|
|
105,289
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
123,128
|
|
|
111,124
|
|
|
65,662
|
|
|
98,945
|
|
||||
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
0.94
|
|
|
$
|
0.85
|
|
|
$
|
0.51
|
|
|
$
|
0.76
|
|
Diluted
|
|
$
|
0.94
|
|
|
$
|
0.85
|
|
|
$
|
0.51
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2015 |
|
June 30,
2015 |
|
September 30,
2015 |
|
December 31,
2015 |
||||||||
Net sales
|
|
$
|
1,103,531
|
|
|
$
|
1,185,002
|
|
|
$
|
1,188,037
|
|
|
$
|
986,766
|
|
Gross profit
|
|
284,546
|
|
|
353,181
|
|
|
311,276
|
|
|
236,188
|
|
||||
Income from operations
|
|
229,280
|
|
|
295,374
|
|
|
254,028
|
|
|
181,145
|
|
||||
Net income
|
|
150,407
|
|
|
210,061
|
|
|
188,420
|
|
|
116,157
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
146,342
|
|
|
205,095
|
|
|
183,604
|
|
|
110,969
|
|
||||
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
1.10
|
|
|
$
|
1.55
|
|
|
$
|
1.39
|
|
|
$
|
0.85
|
|
Diluted
|
|
$
|
1.10
|
|
|
$
|
1.54
|
|
|
$
|
1.39
|
|
|
$
|
0.84
|
|
(1)
|
Basic and diluted earnings per common share ("EPS") for each quarter is computed using the weighted average shares outstanding during that quarter, while EPS for the year is computed using the weighted average shares outstanding for the year. As a result, the sum of the EPS for each of the four quarters may not equal the EPS for the year.
|
(a)(1)
|
The financial statements listed in the Index to Consolidated Financial Statements in Item 8 of this Form 10-K are filed as part of this Form 10-K.
|
|
|
(a)(2)
|
All schedules are omitted because the information is not applicable, not required, or has been furnished in the Consolidated Financial Statements or Notes thereto in Item 8 of this Form 10-K.
|
(a)(3)
|
Exhibits
|
Exhibit No.
|
|
Exhibit
|
|
|
|
2.1
|
|
Share Purchase Agreement dated as of May 28, 2014 by and among Westlake Germany GmbH & Co. KG and various entities associated with Advent International Corporation (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated June 10, 2016, by and among Westlake Chemical Corporation, Lagoon Merger Sub, Inc. and Axiall Corporation (incorporated by reference to Exhibit 2.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260).
|
|
|
|
3.1
|
|
Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on August 6, 2004 (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
3.2
|
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on May 16, 2014 (incorporated by reference to Westlake's Current Report on Form 8-K, filed on May 16, 2014, File No. 001-32260).
|
|
|
|
3.3
|
|
Bylaws of Westlake (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
4.2
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
4.3
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
4.4
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.5
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.6
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
4.7
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 16, 2012, File No. 1-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
4.8
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
4.9
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.10
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.11
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.12
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo, LP, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
4.13
|
|
Eighth Supplemental Indenture (including the form of the Notes), dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
4.14
|
|
Fourth Supplemental Indenture, dated as of August 22, 2016, to the Indenture, dated as of February 1, 2013, by and among Axiall Corporation, the guarantors party thereto and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to Axiall's Current Report on Form 8-K, filed on August 22, 2016, File No. 001-09753).
|
|
|
|
4.15
|
|
Fifth Supplemental Indenture, dated as of August 22, 2016, to the Indenture, dated as of January 28, 2013, by and among Eagles Spinco, In., the guarantors party thereto and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to Axiall's Current Report on Form 8-K, filed on August 22, 2016, File No. 001-09753).
|
|
|
|
4.16
|
|
Ninth Supplemental Indenture (including the form of the Notes) as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and the Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
4.17
|
|
Indenture dated as of September 8, 2016 by and among Westlake and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Registration Statement on Form S-3, filed on September 8, 2016, File No. 333-213548).
|
|
|
|
4.18†
|
|
Supplemental Indenture, dated as of October 25, 2016, among the Company, the Guaranteeing subsidiaries (as defined therein) and the other subsidiary guarantors (as defined therein) and the Bank of New York Mellon Trust Company, as trustee.
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
10.2
|
|
Borrower Joinder Agreement, dated as of May 1, 2013, between North American Specialty Products LLC, a Delaware limited liability company, the Existing Borrowers (as defined therein) and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 4.1 to Westlake's Quarterly Report on Form 10-Q for the quarter ended on June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
10.3
|
|
Credit Agreement, dated as of August 10, 2016, by and between Bank of America, N.A. and Westlake International Holdings II C.V. (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended on September 30, 2016, and filed on November 9, 2016, File No. 001-32260).
|
|
|
|
10.4
|
|
Credit Agreement, dated as of August 23, 2016, by and among Westlake Chemical Corporation, the other borrowers and guarantors referred to therein, the lenders from time to time party thereto, the issuing banks party thereto and JPMorgan Chase Bank, National Association, as Administrative Agent, relating to a $1 billion senior unsecured revolving credit facility (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on August 24, 2016, File No. 001-32260).
|
|
|
|
10.5†
|
|
Joinder Agreement, dated as of October 14, 2016, among JPMorgan Chase Bank, N.A., as Administrative Agent, and certain new guarantors (as defined therein).
|
|
|
|
10.6
|
|
Loan Agreement, dated as of November 1, 2007, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
10.7
|
|
Amended and Restated Loan Agreement, dated as of July 2, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
10.8
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 GO Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
10.9
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 IKE Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
10.10
|
|
Senior Unsecured Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.13 to Westlake Chemical Partners LP's Registration Statement on Form S-1/A, filed on June 30, 2014, File No. 1-36567).
|
|
|
|
10.11
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K filed on April 30, 2015, File No. 1-36567).
|
|
|
|
10.12
|
|
Form of Registration Rights Agreement between Westlake and TTWF LP (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on July 2, 2004).
|
|
|
|
10.13
|
|
Registration Rights Agreement, dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and Deutsche Bank Securities Inc. and Goldman Sachs & Co., as representatives of the Initial Purchasers (as defined therein) (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
10.14
|
|
Registration Rights Agreement, dated as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and Deutsche Bank Securities Inc. and Goldman Sachs & Co., as dealer managers (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
10.15
|
|
Commitment Letter, dated June 10, 2016, by and among Westlake Chemical Corporation, Deutsche Bank AG Cayman Islands Branch, Deutsche Bank Securities Inc. and Goldman Sachs Bank USA (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260).
|
|
|
|
10.16+
|
|
Westlake Chemical Corporation 2013 Omnibus Incentive Plan (as amended and restated as of May 17, 2013) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 22, 2013, File No.1-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
10.17+
|
|
Form of Stock Option Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
10.18+
|
|
Westlake Chemical Corporation Amended and Restated Annual Incentive Plan adopted by the Compensation Committee of the Board of Directors on March 24, 2011 (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed on May 4, 2011, File No. 1-32260).
|
|
|
|
10.19+
|
|
Form of Restricted Stock Units Award Letter effective as of February 15, 2013 (incorporated by reference to Exhibit 10.29 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
10.20+
|
|
Form of Stock Option Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
10.21+
|
|
Form of Restricted Stock Units Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
10.22+
|
|
Form of Long-Term Cash Performance Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.5 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
12.1†
|
|
Statement of computation of ratio of earnings to fixed charges for the years ended December 31, 2016, 2015, 2014, 2013 and 2012
|
|
|
|
21†
|
|
Subsidiaries of Westlake.
|
|
|
|
23.1†
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
31.1†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Executive Officer).
|
|
|
|
31.2†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Financial Officer).
|
|
|
|
32.1†
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
101.INS†
|
|
XBRL Instance Document.
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
†
|
Filed herewith.
|
+
|
Management contract, compensatory plan or arrangement.
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
|
|
|
|
Date:
|
February 22, 2017
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
Albert Chao, President and Chief Executive Officer
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/
S
/ A
LBERT
C
HAO
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 22, 2017
|
Albert Chao
|
|
|||
|
|
|
||
/
S
/ M. S
TEVEN
B
ENDER
|
|
Senior Vice President, Chief Financial Officer
and Treasurer (Principal Financial Officer)
|
|
February 22, 2017
|
M. Steven Bender
|
|
|||
|
|
|
||
/
S
/ G
EORGE
J. M
ANGIERI
|
|
Vice President and Chief Accounting Officer
(Principal Accounting Officer)
|
|
February 22, 2017
|
George J. Mangieri
|
|
|||
|
|
|
||
/
S
/ J
AMES
C
HAO
|
|
Chairman of the Board of Directors
|
|
February 22, 2017
|
James Chao
|
|
|||
|
|
|
||
/
S
/ A
LBERT
C
HAO
|
|
Director
|
|
February 22, 2017
|
Albert Chao
|
|
|||
|
|
|
||
/
S
/ R
OBERT
T. B
LAKELY
|
|
Director
|
|
February 22, 2017
|
Robert T. Blakely
|
|
|||
|
|
|
||
/
S
/ M
ICHAEL
J. G
RAFF
|
|
Director
|
|
February 22, 2017
|
Michael J. Graff
|
|
|||
|
|
|
||
/
S
/ D
OROTHY
C. J
ENKINS
|
|
Director
|
|
February 22, 2017
|
Dorothy C. Jenkins
|
|
|||
|
|
|
||
/
S
/ M
AX
L. L
UKENS
|
|
Director
|
|
February 22, 2017
|
Max L. Lukens
|
|
|||
|
|
|
||
/S/ R. B
RUCE
N
ORTHCUTT
|
|
Director
|
|
February 22, 2017
|
R. Bruce Northcutt
|
|
|||
|
|
|
|
|
/
S
/ H. J
OHN
R
ILEY
, J
R
.
|
|
Director
|
|
February 22, 2017
|
H. John Riley, Jr.
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
2.1
|
|
Share Purchase Agreement dated as of May 28, 2014 by and among Westlake Germany GmbH & Co. KG and various entities associated with Advent International Corporation (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated June 10, 2016, by and among Westlake Chemical Corporation, Lagoon Merger Sub, Inc. and Axiall Corporation (incorporated by reference to Exhibit 2.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260).
|
|
|
|
3.1
|
|
Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on August 6, 2004 (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
3.2
|
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on May 16, 2014 (incorporated by reference to Westlake's Current Report on Form 8-K, filed on May 16, 2014, File No. 001-32260).
|
|
|
|
3.3
|
|
Bylaws of Westlake (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
4.2
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
4.3
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
4.4
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.5
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
4.6
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
4.7
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 16, 2012, File No. 1-32260).
|
|
|
|
4.8
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
4.9
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.10
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
4.11
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
4.12
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo, LP, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
4.13
|
|
Eighth Supplemental Indenture (including the form of the Notes), dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
4.14
|
|
Fourth Supplemental Indenture, dated as of August 22, 2016, to the Indenture, dated as of February 1, 2013, by and among Axiall Corporation, the guarantors party thereto and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to Axiall's Current Report on Form 8-K, filed on August 22, 2016, File No. 001-09753).
|
|
|
|
4.15
|
|
Fifth Supplemental Indenture, dated as of August 22, 2016, to the Indenture, dated as of January 28, 2013, by and among Eagles Spinco, In., the guarantors party thereto and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to Axiall's Current Report on Form 8-K, filed on August 22, 2016, File No. 001-09753).
|
|
|
|
4.16
|
|
Ninth Supplemental Indenture (including the form of the Notes) as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and the Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
4.17
|
|
Indenture dated as of September 8, 2016 by and among Westlake and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Registration Statement on Form S-3, filed on September 8, 2016, File No. 333-213548).
|
|
|
|
4.18†
|
|
Supplemental Indenture, dated as of October 25, 2016, among the Company, the Guaranteeing subsidiaries (as defined therein) and the other subsidiary guarantors (as defined therein) and the Bank of New York Mellon Trust Company, as trustee.
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
10.2
|
|
Borrower Joinder Agreement, dated as of May 1, 2013, between North American Specialty Products LLC, a Delaware limited liability company, the Existing Borrowers (as defined therein) and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 4.1 to Westlake's Quarterly Report on Form 10-Q for the quarter ended on June 30, 2013, and filed on July 31, 2013, File No. 1-32260).
|
|
|
|
10.3
|
|
Credit Agreement, dated as of August 10, 2016, by and between Bank of America, N.A. and Westlake International Holdings II C.V. (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended on September 30, 2016, and filed on November 9, 2016, File No. 001-32260).
|
|
|
|
10.4
|
|
Credit Agreement, dated as of August 23, 2016, by and among Westlake Chemical Corporation, the other borrowers and guarantors referred to therein, the lenders from time to time party thereto, the issuing banks party thereto and JPMorgan Chase Bank, National Association, as Administrative Agent, relating to a $1 billion senior unsecured revolving credit facility (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on August 24, 2016, File No. 001-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
10.5†
|
|
Joinder Agreement, dated as of October 14, 2016, among JPMorgan Chase Bank, N.A., as Administrative Agent, and certain new guarantors (as defined therein).
|
|
|
|
10.6
|
|
Loan Agreement, dated as of November 1, 2007, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
10.7
|
|
Amended and Restated Loan Agreement, dated as of July 2, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
10.8
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 GO Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
10.9
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 IKE Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
10.10
|
|
Senior Unsecured Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.13 to Westlake Chemical Partners LP's Registration Statement on Form S-1/A, filed on June 30, 2014, File No. 1-36567).
|
|
|
|
10.11
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K filed on April 30, 2015, File No. 1-36567).
|
|
|
|
10.12
|
|
Form of Registration Rights Agreement between Westlake and TTWF LP (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on July 2, 2004).
|
|
|
|
10.13
|
|
Registration Rights Agreement, dated as of August 10, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and Deutsche Bank Securities Inc. and Goldman Sachs & Co., as representatives of the Initial Purchasers (as defined therein) (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on August 10, 2016, File No. 001-32260).
|
|
|
|
10.14
|
|
Registration Rights Agreement, dated as of September 7, 2016, among Westlake Chemical Corporation, the Guarantors (as defined therein) and Deutsche Bank Securities Inc. and Goldman Sachs & Co., as dealer managers (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on September 7, 2016, File No. 001-32260).
|
|
|
|
10.15
|
|
Commitment Letter, dated June 10, 2016, by and among Westlake Chemical Corporation, Deutsche Bank AG Cayman Islands Branch, Deutsche Bank Securities Inc. and Goldman Sachs Bank USA (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260).
|
|
|
|
10.16+
|
|
Westlake Chemical Corporation 2013 Omnibus Incentive Plan (as amended and restated as of May 17, 2013) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 22, 2013, File No.1-32260).
|
|
|
|
10.17+
|
|
Form of Stock Option Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
10.18+
|
|
Westlake Chemical Corporation Amended and Restated Annual Incentive Plan adopted by the Compensation Committee of the Board of Directors on March 24, 2011 (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed on May 4, 2011, File No. 1-32260).
|
|
|
|
10.19+
|
|
Form of Restricted Stock Units Award Letter effective as of February 15, 2013 (incorporated by reference to Exhibit 10.29 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
10.20+
|
|
Form of Stock Option Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
10.21+
|
|
Form of Restricted Stock Units Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
10.22+
|
|
Form of Long-Term Cash Performance Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.5 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
12.1†
|
|
Statement of computation of ratio of earnings to fixed charges for the years ended December 31, 2016, 2015, 2014, 2013 and 2012
|
|
|
|
21†
|
|
Subsidiaries of Westlake.
|
|
|
|
23.1†
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
31.1†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Executive Officer).
|
|
|
|
31.2†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Financial Officer).
|
|
|
|
32.1†
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
101.INS†
|
|
XBRL Instance Document.
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
†
|
Filed herewith.
|
+
|
Management contract, compensatory plan or arrangement.
|
GEISMAR HOLDINGS, INC.
GVGP, INC.
WESTLAKE CHEMICAL INVESTMENTS, INC.
WESTLAKE GEISMAR POWER COMPANY LLC
BY WESTLAKE VINYLS COMPANY LP,
ITS MANAGER
BY GVGP, INC.,
ITS GENERAL PARTNER
WESTLAKE LONGVIEW CORPORATION
WESTLAKE MANAGEMENT SERVICES, INC. WESTLAKE NG I CORPORATION WESTLAKE OLEFINS CORPORATION
WESTLAKE PIPELINE INVESTMENTS LLC,
BY WESTLAKE CHEMICAL INVESTMENTS, INC.,
ITS MANAGER
WESTLAKE POLYMERS LLC,
BY WESTLAKE CHEMICAL INVESTMENTS, INC.,
ITS MANAGER
WESTLAKE PVC CORPORATION
WESTLAKE RESOURCES CORPORATION WESTLAKE STYRENE LLC,
BY WESTLAKE CHEMICAL INVESTMENTS, INC.,
ITS MANAGER
WESTLAKE SUPPLY AND TRADING COMPANY
WESTLAKE VINYL CORPORATION WESTLAKE VINYLS COMPANY LP,
BY GVGP, INC.,
ITS GENERAL PARTNER
WESTLAKE VINYLS, INC.
WPT LLC,
BY WESTLAKE CHEMICAL INVESTMENTS, INC.,
ITS MANAGER WESTLAKE PETROCHEMICALS LLC, BY WESTLAKE CHEMICAL INVESTMENTS, INC.,
ITS MANAGER
|
|
By:
/s/ Albert Chao
|
|
Name: Albert Chao
|
|
Title: President
|
|
WESTECH BUILDING PRODUCTS (EVANSVILLE) LLC
BY WESTECH BUILDING PRODUCTS, INC.,
ITS MANAGER
NORTH AMERICAN SPECIALTY PRODUCTS LLC,
BY NORTH AMERICAN PIPE CORPORATION,
ITS MANAGER
|
||
By:
/s/ Robert F. Buesinger
|
|
|
Name: Robert F. Buesinger
|
|
|
Title: President
|
|
|
|
|
JPMORGAN CHASE BANK, N.A., as Administrative Agent
|
|
By:
|
/s/ John Kushnerick
|
Name: John Kushnerick
|
|
Title: Executive Director
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
Earnings
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Income before Income Taxes
|
|
$
|
558,379
|
|
|
$
|
963,441
|
|
|
$
|
1,083,918
|
|
|
$
|
942,172
|
|
|
$
|
585,169
|
|
Fixed Charges
|
|
122,128
|
|
|
70,261
|
|
|
64,755
|
|
|
60,593
|
|
|
65,002
|
|
|||||
Amortization of Capitalized Interest
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Equity Investee Distributions
|
|
5,116
|
|
|
5,610
|
|
|
5,459
|
|
|
5,114
|
|
|
4,449
|
|
|||||
Capitalized Interest
|
|
(10,388
|
)
|
|
(10,449
|
)
|
|
(7,059
|
)
|
|
(25,932
|
)
|
|
(7,706
|
)
|
|||||
Equity Investment (Income) Loss
|
|
(52,693
|
)
|
|
(22,362
|
)
|
|
864
|
|
|
(4,914
|
)
|
|
(1,444
|
)
|
|||||
Total Earnings Available for Fixed Charges
|
|
$
|
622,542
|
|
|
$
|
1,006,501
|
|
|
$
|
1,147,937
|
|
|
$
|
977,033
|
|
|
$
|
645,470
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed Charges
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest Expense
|
|
$
|
79,473
|
|
|
$
|
34,656
|
|
|
$
|
37,352
|
|
|
$
|
18,082
|
|
|
$
|
43,049
|
|
Capitalized Interest
|
|
10,388
|
|
|
10,449
|
|
|
7,059
|
|
|
25,932
|
|
|
7,706
|
|
|||||
Amortization of Debt Issue Costs
|
|
3,159
|
|
|
2,004
|
|
|
1,673
|
|
|
1,459
|
|
|
1,514
|
|
|||||
Portion of Rentals
|
|
29,108
|
|
|
23,152
|
|
|
18,671
|
|
|
15,120
|
|
|
12,733
|
|
|||||
Total Fixed Charges
|
|
$
|
122,128
|
|
|
$
|
70,261
|
|
|
$
|
64,755
|
|
|
$
|
60,593
|
|
|
$
|
65,002
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Ratio of Earnings to Fixed Charges
|
|
5.1
|
|
|
14.3
|
|
|
17.7
|
|
|
16.1
|
|
|
9.9
|
|
Name of Subsidiary
|
|
State or Other Jurisdiction
of Incorporation or
Organization
|
|
Names Doing Business
|
|
|
|
|
|
6630987 Canada, Inc.
|
|
Canada
|
|
6630987 Canada, Inc.
|
|
|
|
|
|
Axiall Canada, Inc.
|
|
Canada
|
|
Axiall Canada, Inc.
|
|
|
|
|
|
Axiall Corporation
|
|
Delaware
|
|
Axiall Corporation
|
|
|
|
|
|
Axiall Holdco, Inc.
|
|
Delaware
|
|
Axiall Holdco, Inc.
|
|
|
|
|
|
Axiall Limited Partnership
|
|
Canada
|
|
Axiall Limited Partnership
|
|
|
|
|
|
Axiall Noteco, Inc.
|
|
Delaware
|
|
Axiall Noteco, Inc.
|
|
|
|
|
|
Axiall Ohio, Inc.
|
|
Delaware
|
|
Axiall Ohio, Inc.
|
|
|
|
|
|
Axiall Taiwan Ltd.
|
|
Taiwan
|
|
Axiall Taiwan Ltd.
|
|
|
|
|
|
Axiall, LLC
|
|
Delaware
|
|
Axiall, LLC
|
|
|
|
|
|
Eagle Holdco 3 LLC
|
|
Delaware
|
|
Eagle Holdco 3 LLC
|
|
|
|
|
|
Eagle Natrium LLC
|
|
Delaware
|
|
Eagle Natrium LLC
|
|
|
|
|
|
Eagle Pipeline, Inc.
|
|
Louisiana
|
|
Eagle Pipeline, Inc.
|
|
|
|
|
|
Eagle Spinco Inc.
|
|
Delaware
|
|
Eagle Spinco Inc.
|
|
|
|
|
|
Eagle US 2 LLC
|
|
Delaware
|
|
Eagle US 2 LLC
|
|
|
|
|
|
EPS Ethylen-Pipeline-Sud Geschaftsfuhrungs GmbH
|
|
Germany
|
|
EPS Ethylen-Pipeline-Sud Geschaftsfuhrungs GmbH
|
|
|
|
|
|
EPS Ethylen-Pipeline-Sud GmbH & Co. KG
|
|
Germany
|
|
EPS Ethylen-Pipeline-Sud GmbH & Co. KG
|
|
|
|
|
|
George Gulf Lake Charles, LLC
|
|
Delaware
|
|
George Gulf Lake Charles, LLC
|
|
|
|
|
|
InfraServ GmbH & Co. Gendorf KG
|
|
Germany
|
|
InfraServ GmbH & Co. Gendorf KG
|
|
|
|
|
|
InfraServ GmbH & Co. Knapsack KG
|
|
Germany
|
|
InfraServe GmbH & Co. Knapsack KG
|
|
|
|
|
|
LACC, LLC
|
|
Delaware
|
|
LACC, LLC
|
|
|
|
|
|
Lagoon LLC
|
|
Delaware
|
|
Lagoon LLC
|
|
|
|
|
|
Mexaxiall, S. de R.L. de C.V.
|
|
Mexico
|
|
Mexaxiall, S. de R.L. de C.V.
|
|
|
|
|
|
North American Pipe Corporation
|
|
Delaware
|
|
North American Pipe Corporation
and NAPCO
|
|
|
|
|
|
North American Specialty Products LLC
|
|
Delaware
|
|
North American Specialty Products LLC
|
|
|
|
|
|
PHH Monomers, LLC
|
|
Louisiana
|
|
PHH Monomers, LLC
|
|
|
|
|
|
Plastic Trends, Inc.
|
|
Michigan
|
|
Plastic Trends, Inc.
|
|
|
|
|
|
Rome Acquisition Holding Corp.
|
|
Nova Scotia
|
|
Rome Acquisition Holding Corp.
|
|
|
|
|
|
Rome Delaware Corp.
|
|
Delaware
|
|
Rome Delaware Corp.
|
|
|
|
|
|
Royal Building Products (USA) Inc.
|
|
Delaware
|
|
Royal Building Products (USA) Inc.
|
Royal Group, Inc. Groupe Royal, Inc.
|
|
Canada
|
|
Royal Group, Inc. Groupe Royal, Inc.
|
|
|
|
|
|
Royal Plastics Group (U.S.A.) Limited
|
|
Delaware
|
|
Royal Plastics Group (U.S.A.) Limited
|
|
|
|
|
|
Royal Ventures Construction & Development Inc.
|
|
Philippines
|
|
Royal Ventures Construction & Development Inc.
|
|
|
|
|
|
Royal Ventures Land Holdings Corp.
|
|
Philippines
|
|
Royal Ventures Land Holdings Corp.
|
|
|
|
|
|
Royal Window and Door Profiles Plant 13 Inc.
|
|
Pennsylvania
|
|
Royal Window and Door Profiles Plant 13 Inc.
|
|
|
|
|
|
Royal Window and Door Profiles Plant 14 Inc.
|
|
Washington
|
|
Royal Window and Door Profiles Plant 14 Inc.
|
|
|
|
|
|
RS Cogen, L.L.C.
|
|
Louisiana
|
|
RS Cogen, L.L.C.
|
|
|
|
|
|
Shriram Axiall Private Limited
|
|
India
|
|
Shriram Axiall Private Limited
|
|
|
|
|
|
Taiwan Chlorine Industries Ltd.
|
|
Taiwan
|
|
Taiwan Chlorine Industries Ltd.
|
|
|
|
|
|
Vinnolit Benelux-France B.V.B.A.
|
|
Dendermonde, Belgium
|
|
Vinnolit Benelux-France B.V.B.A.
|
|
|
|
|
|
Vinnolit GmbH & Co. KG
|
|
Ismaning, Germany
|
|
Vinnolit GmbH & Co. KG
|
|
|
|
|
|
Vinnolit Hillhouse Ltd.
|
|
Lancashire, England
|
|
Vinnolit Hillhouse Ltd.
|
|
|
|
|
|
Vinnolit Italia S.r.L.
|
|
Milan, Italy
|
|
Vinnolit Italia S.r.L.
|
|
|
|
|
|
Vinnolit Ltd.
|
|
United Kingdom
|
|
Vinnolit Ltd.
|
|
|
|
|
|
Vinnolit Schkopau GmbH
|
|
Ismaning, Germany
|
|
Vinnolit Schkopau GmbH
|
|
|
|
|
|
Vinyl Solutions, LLC
|
|
Delaware
|
|
Vinyl Solutions, LLC
|
|
|
|
|
|
Westech Building Products, Inc.
|
|
Delaware
|
|
Westech Building Products, Inc.
|
|
|
|
|
|
Westech Building Products ULC
|
|
Canada
|
|
Westech Building Products ULC and
Westech Building Products Limited
|
|
|
|
|
|
Westlake Chemical Finance Corporation
|
|
Delaware
|
|
Westlake Chemical Finance Corporation
|
|
|
|
|
|
Westlake Chemical OpCo LP
|
|
Delaware
|
|
Westlake Chemical OpCo LP
|
|
|
|
|
|
Westlake Chemical Partners LP
|
|
Delaware
|
|
Westlake Chemical Partners LP
|
|
|
|
|
|
Westlake Germany GmbH & Co. KG
|
|
Ismaning, Germany
|
|
Westlake Germany GmbH & Co. KG
|
|
|
|
|
|
Westlake International Holdings C.V.
|
|
The Netherlands
|
|
Westlake International Holdings C.V.
|
|
|
|
|
|
Westlake Longview Corporation
|
|
Delaware
|
|
Westlake Longview Corporation
|
|
|
|
|
|
Westlake Management Services, Inc.
|
|
Delaware
|
|
Westlake Management Services, Inc.
|
|
|
|
|
|
Westlake Petrochemicals LLC
|
|
Delaware
|
|
Westlake Petrochemicals LLC,
Westlake Petrochemicals LP and WPE
|
|
|
|
|
|
Westlake Polymers LLC
|
|
Delaware
|
|
Westlake Polymers LLC,
Westlake Polymers LP and WPE
|
|
|
|
|
|
Westlake PVC Corporation
|
|
Delaware
|
|
Westlake PVC Corporation
|
|
|
|
|
|
Westlake Styrene LLC
|
|
Delaware
|
|
Westlake Styrene LLC and
Westlake Styrene LP
|
|
|
|
|
|
Westlake Supply and Trading Company
|
|
Delaware
|
|
Westlake Supply and Trading Company
|
|
|
|
|
|
Westlake Vinyls Company LP
|
|
Delaware
|
|
Westlake Vinyls Company LP
|
|
|
|
|
|
Westlake Vinyls, Inc.
|
|
Delaware
|
|
Westlake Vinyls, Inc.,
Westlake Monomers and WCAO
|
|
|
|
|
|
WPT LLC
|
|
Delaware
|
|
WPT LLC and WPT LP
|
|
|
|
|
|
Suzhou Huasu Plastics Co., Ltd.
|
|
People’s Republic of China
|
|
Suzhou Huasu Plastics Co., Ltd.
and Huasu
|
*
|
Westlake has elected to omit the names of certain subsidiaries. None of the omitted subsidiaries, considered either alone or together with the other omitted subsidiaries of its immediate parent, constitutes a “Significant Subsidiary” as set forth in Section 601(b)(21) of Regulation S-K.
|
1.
|
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 22, 2017
|
|
/s/ A
LBERT
C
HAO
|
|
|
|
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer) |
1.
|
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 22, 2017
|
|
/s/ M. S
TEVEN
B
ENDER
|
|
|
|
M. Steven Bender
Senior Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 22, 2017
|
|
/s/ A
LBERT
C
HAO
|
|
|
|
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
Date:
|
February 22, 2017
|
|
/s/ M. S
TEVEN
B
ENDER
|
|
|
|
M. Steven Bender
Senior Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
|